cy-10q_20160703.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 3, 2016

OR

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 1-10079

 

CYPRESS SEMICONDUCTOR CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

94-2885898

 

 

 

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

198 Champion Court, San Jose, California 95134

(Address of principal executive offices and zip code)

(408) 943-2600

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

 

x

 

Accelerated filer

 

¨

 

 

 

 

 

 

 

Non-accelerated filer

 

o  (Do not check if a smaller reporting company)

 

Smaller reporting company

 

¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  x

The total number of outstanding shares of the registrant’s common stock as of August 2, 2016 was 321,180,733.

 

 

 

 

 


 

INDEX

 

 

 

Page

PART I—FINANCIAL INFORMATION

Forward-Looking Statements

3

 

 

 

Item 1.

Condensed Consolidated Financial Statements (Unaudited)

4

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

32

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

45

Item 4.

Controls and Procedures

46

 

PART II—OTHER INFORMATION

Item 1.

Legal Proceedings

47

Item 1A.

Risk Factors

47

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

50

Item 3.

Defaults Upon Senior Securities

51

Item 4.

Mine Safety Disclosures

51

Item 5.

Other Information

51

Item 6.

Exhibits

52

 

Signatures

53

 

Exhibit Index

54

 

2


 

PART I—FINANCIAL INFORMATION

Forward-Looking Statements

The discussion in this Quarterly Report on Form 10-Q contains statements that are not historical in nature, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. Forward-looking statements include, but are not limited to, statements relating to: the expected timing and costs related to the integration of Cypress Semiconductor Corporation (“Cypress” or the “Company”) with Spansion Inc. (“Spansion”) as a result of our merger; our ability to execute on planned synergies related to the merger with Spansion and our related restructuring activities; the anticipated timing of the payout of the remaining Spansion restructuring reserve balance; the anticipated technological feasibility of our in-process research and development; estimated further amortization expense related to intangible assets; our expectations regarding our active litigation matters and our intent to defend ourselves in those matters; events that could cause a material change in unrecognized tax benefits and our ability to recognize those benefits; the specific strategies we are pursuing to achieve our goals on revenue growth and profitability; our ability to position the Company in high-growth markets; the value of non-GAAP financial measures to investors; the estimates we make in preparing our financial statements, including but not limited to those relating to our critical accounting policies; the expected impact on our operating results of changes in market interest rates applicable to our investment portfolio;  our expectations regarding dividends and the tax treatment of dividends for recipients; our expectations regarding stock repurchases;; our foreign currency exposure and the impact exchange rates could have on our operating results; and the adequacy of our cash and working capital positions; the value and liquidity of our investments. We use words such as “may,” “will,” “should,” “expect,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” and similar expressions to identify forward-looking statements. Such forward-looking statements are made as of the date hereof and are based on our current expectations, beliefs and intentions regarding future events or our financial performance and the information available to management as of the date hereof. We assume no responsibility to update any such forward-looking statements. Our actual results could differ materially from those expected, discussed or projected in the forward-looking statements contained in this Quarterly Report on Form 10-Q for any number of reasons, including, but not limited to: global economic and market conditions; business conditions and growth trends in the semiconductor market; our ability to compete effectively; the volatility in supply and demand conditions for our products, including but limited to the impact of seasonality on supply and demand; our ability to develop, introduce and sell new products and technologies; potential problems relating to our manufacturing activities; the impact of acquisitions, including but limited to the continuing integration of Spansion and the recent acquisition of Broadcom’s wireless IoT business; our ability to attract and retain key personnel, including a new President and Chief Executive Officer; and/or the materialization of one or more of the risks set forth in Item 1A (Risk Factors) in this Quarterly Report on Form 10-Q and in Part I, Item 1A (Risk Factors) in our Annual Report on Form 10-K for the fiscal year ended January 3, 2016.

 

 

3


 

ITEM 1. FINANCIAL STATEMENTS

CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

 

 

July 3,

2016

 

 

January 3,

2016

 

 

 

(In thousands, except

per-share amounts)

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

188,333

 

 

$

226,690

 

Short-term investments

 

 

970

 

 

 

871

 

Accounts receivable, net

 

 

325,142

 

 

 

292,736

 

Inventories

 

 

220,890

 

 

 

243,595

 

Other current assets

 

 

127,670

 

 

 

86,880

 

Total current assets

 

 

863,005

 

 

 

850,772

 

Property, plant and equipment, net

 

 

402,369

 

 

 

425,003

 

Goodwill

 

 

1,250,378

 

 

 

1,738,882

 

Intangible assets, net

 

 

686,885

 

 

 

789,195

 

Other long-term assets

 

 

201,117

 

 

 

200,409

 

Total assets

 

$

3,403,754

 

 

$

4,004,261

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

174,389

 

 

$

143,383

 

Accrued compensation and employee benefits

 

 

57,390

 

 

 

54,850

 

Deferred margin on sales to distributors

 

 

19,052

 

 

 

73,370

 

Dividends payable

 

 

35,240

 

 

 

36,520

 

Income taxes payable

 

 

3,581

 

 

 

3,262

 

Current portion of debt

 

 

13,436

 

 

 

14,606

 

Price adjustment reserve for sales to distributors

 

 

102,826

 

 

 

52,712

 

Other current liabilities

 

 

127,313

 

 

 

149,693

 

Total current liabilities

 

 

533,227

 

 

 

528,396

 

Deferred income taxes and other tax liabilities

 

 

45,950

 

 

 

51,737

 

Revolving credit facility and long-term debt

 

 

820,364

 

 

 

673,659

 

Other long-term liabilities

 

 

41,163

 

 

 

37,784

 

Total liabilities

 

 

1,440,704

 

 

 

1,291,576

 

Commitments and contingencies (Note 10)

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

 

 

Preferred stock, $.01 par value, 5,000 shares authorized; none issued and outstanding

 

 

 

 

 

 

Common stock, $.01 par value, 650,000 and 650,000 shares authorized; 494,273 and

   481,912 shares issued;320,809 and 332,276 shares outstanding at July 3,

   2016 and January 3, 2016 respectively

 

 

4,721

 

 

 

4,637

 

Additional paid-in-capital

 

 

5,679,928

 

 

 

5,623,411

 

Accumulated other comprehensive gain / (loss)

 

 

1,552

 

 

 

(227

)

Accumulated deficit

 

 

(1,382,077

)

 

 

(758,780

)

Stockholders’ equity before treasury stock

 

 

4,304,124

 

 

 

4,869,041

 

Less: Shares of common stock held in treasury, at cost; 173,464 and 149,636 shares at

   July 3, 2016 and January 3, 2016 respectively

 

 

(2,335,289

)

 

 

(2,148,193

)

Total Cypress stockholders’ equity

 

 

1,968,835

 

 

 

2,720,848

 

Non-controlling interests

 

 

(5,785

)

 

 

(8,163

)

Total equity

 

 

1,963,050

 

 

 

2,712,685

 

Total liabilities and equity

 

$

3,403,754

 

 

$

4,004,261

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

4


 

CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands, except per-share amounts)

 

Revenues

 

$

450,127

 

 

$

484,778

 

 

$

869,091

 

 

$

693,915

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenues

 

 

291,349

 

 

 

346,705

 

 

 

584,528

 

 

 

597,535

 

Research and development

 

 

70,171

 

 

 

81,227

 

 

 

144,138

 

 

 

131,749

 

Selling, general and administrative

 

 

81,836

 

 

 

91,840

 

 

 

156,336

 

 

 

162,300

 

Amortization of intangible assets

 

 

32,605

 

 

 

35,928

 

 

 

67,792

 

 

 

43,274

 

Impairment of acquisition-related intangible assets

 

 

 

 

 

 

 

 

33,944

 

 

 

 

Goodwill impairment charge

 

 

488,504

 

 

 

 

 

 

488,504

 

 

 

 

Restructuring costs

 

 

654

 

 

 

10,039

 

 

 

924

 

 

 

85,754

 

Total costs and expenses

 

 

965,119

 

 

 

565,739

 

 

 

1,476,166

 

 

 

1,020,612

 

Operating loss

 

 

(514,992

)

 

 

(80,961

)

 

 

(607,075

)

 

 

(326,697

)

Interest expense

 

 

(7,540

)

 

 

(5,041

)

 

 

(13,872

)

 

 

(7,124

)

Other income (expense), net

 

 

224

 

 

 

(295

)

 

 

305

 

 

 

(2,361

)

Loss before income taxes and non-controlling interest

 

 

(522,308

)

 

 

(86,297

)

 

 

(620,642

)

 

 

(336,182

)

Income tax benefit (provision)

 

 

5,221

 

 

 

(2,935

)

 

 

1,479

 

 

 

1,068

 

Share in net loss of equity method investee

 

 

(2,568

)

 

 

(1,459

)

 

 

(4,646

)

 

 

(3,018

)

Net loss

 

 

(519,655

)

 

 

(90,691

)

 

 

(623,809

)

 

 

(338,132

)

Net loss attributable to non-controlling interests

 

 

381

 

 

 

640

 

 

 

513

 

 

 

1,283

 

Net loss attributable to Cypress

 

$

(519,274

)

 

$

(90,051

)

 

$

(623,296

)

 

$

(336,849

)

Net loss per share attributable to Cypress:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(1.65

)

 

$

(0.27

)

 

$

(1.96

)

 

$

(1.27

)

Diluted

 

$

(1.65

)

 

$

(0.27

)

 

$

(1.96

)

 

$

(1.27

)

Cash dividend declared per share

 

$

0.11

 

 

$

0.11

 

 

$

0.22

 

 

$

0.22

 

Shares used in net loss per share calculation:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

314,305

 

 

 

333,334

 

 

 

317,330

 

 

 

264,547

 

Diluted

 

 

314,305

 

 

 

333,334

 

 

 

317,330

 

 

 

264,547

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

5


 

CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

Net loss

 

$

(519,655

)

 

$

(90,691

)

 

$

(623,809

)

 

$

(338,132

)

Other comprehensive loss, net of taxes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net change in unrealized (losses) gains on available for sale

   securities

 

 

 

 

 

(1

)

 

 

 

 

 

26

 

Net unrealized gain (loss) on cash flow hedges:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net unrealized loss arising during the period

 

 

(7,951

)

 

 

(1,549

)

 

 

(10,629

)

 

 

(1,741

)

Net loss reclassified into earnings for revenue hedges

   (effective portion)

 

 

4,102

 

 

 

193

 

 

 

5,127

 

 

 

390

 

Net loss reclassified into earnings for revenue hedges

   (ineffective portion)

 

 

(184

)

 

 

 

 

 

(173

)

 

 

 

 

Net loss (gain) reclassified into earnings for expense hedges

   (effective portion)

 

 

4,665

 

 

 

233

 

 

 

7,454

 

 

 

162

 

Net unrealized gain (loss) on cash flow hedges

 

 

632

 

 

 

(1,123

)

 

 

1,779

 

 

 

(1,189

)

Other comprehensive gain (loss)

 

 

632

 

 

 

(1,124

)

 

 

1,779

 

 

 

(1,163

)

Comprehensive loss

 

 

(519,023

)

 

 

(91,815

)

 

 

(622,030

)

 

 

(339,295

)

Comprehensive loss attributable to non-controlling interest

 

 

381

 

 

 

640

 

 

 

513

 

 

 

1,283

 

Comprehensive loss attributable to Cypress

 

$

(518,642

)

 

$

(91,175

)

 

$

(621,517

)

 

$

(338,012

)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

6


 

CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(623,809

)

 

$

(338,132

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

Stock-based compensation expense

 

 

42,387

 

 

 

46,464

 

Depreciation and amortization

 

 

122,737

 

 

 

96,641

 

Impairment of acquisition-related intangible assets

 

 

33,944

 

 

 

 

Impairment of goodwill

 

 

488,504

 

 

 

 

Loss on disposal of property and equipment

 

 

6,116

 

 

 

9,346

 

Share in net loss of equity method investee

 

 

4,646

 

 

 

3,018

 

Accretion of interest expense on Senior Exchangeable Notes

 

 

2,039

 

 

 

 

Loss (gain) on assets held under deferred compensation plan

 

 

793

 

 

 

(1,204

)

Unrealized loss on trading securities

 

 

598

 

 

 

191

 

Restructuring and other costs

 

 

2,464

 

 

 

13,768

 

Changes in operating assets and liabilities, net of acquisition and divestiture

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(32,406

)

 

 

(85,418

)

Inventories

 

 

22,383

 

 

 

238,884

 

Other current and long-term assets

 

 

(36,656

)

 

 

(15,519

)

Price adjustment reserve for sales to distributors

 

 

50,114

 

 

 

13,951

 

Accounts payable and other liabilities

 

 

(6,815

)

 

 

(67,095

)

Deferred margin on sales to distributors

 

 

(54,536

)

 

 

32,089

 

Net cash provided by (used in) operating activities

 

 

22,503

 

 

 

(53,016

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchases of marketable securities

 

 

(80,053

)

 

 

(1,530

)

Proceeds from maturities of available-for-sale investments

 

 

40,000

 

 

 

7,187

 

Proceeds from sales of available-for-sale investments

 

 

44,317

 

 

 

 

Business acquisition, net of cash acquired

 

 

 

 

 

(105,130

)

Contribution, net of distributions to deferred compensation plan

 

 

1,743

 

 

 

1,270

 

Acquisition of property, plant and equipment

 

 

(25,814

)

 

 

(25,231

)

Cash paid for equity and cost method investments, and other

 

 

(14,376

)

 

 

(11,877

)

Net cash used in investing activities

 

 

(34,183

)

 

 

(135,311

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Borrowings under revolving credit facility

 

 

120,000

 

 

 

299,000

 

Repayment of revolving credit facility

 

 

(202,000

)

 

 

(77,000

)

Repayment of Term Loan A

 

 

(2,500

)

 

 

 

Repurchase of treasury stock

 

 

(175,694

)

 

 

(10,382

)

Payment of dividends

 

 

(70,820

)

 

 

(54,334

)

Proceeds from employee equity awards

 

 

40,111

 

 

 

33,199

 

Repayment of equipment leases, loans, net and other

 

 

(6,606

)

 

 

(4,486

)

Net proceeds from issuance of 4.50% Senior Exchangeable Notes

 

 

279,594

 

 

 

 

Purchase of capped calls

 

 

(8,165

)

 

 

 

Proceeds from settlement of capped calls

 

 

 

 

 

25,293

 

Financing costs related to revolving credit facility

 

 

(597

)

 

 

(2,559

)

Net cash (used in) provided byfinancing activities

 

 

(26,677

)

 

 

208,731

 

Net (decrease) increase in cash and cash equivalents

 

 

(38,357

)

 

 

20,404

 

Cash and cash equivalents, beginning of period

 

 

226,690

 

 

 

103,736

 

Cash and cash equivalents, end of period

 

$

188,333

 

 

$

124,140

 

Supplemental Cash Flows Disclosures:

 

 

 

 

 

 

 

 

Dividends payable

 

$

35,240

 

 

$

36,718

 

Unpaid purchase of property, plant and equipment

 

$

3,804

 

 

$

10,578

 

Cash paid for interest

 

$

10,398

 

 

$

4,268

 

Cash paid for income taxes

 

$

4,742

 

 

$

4,220

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

 

7


 

CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Fiscal Years

Cypress Semiconductor Corporation (“Cypress” or the “Company”) reports on a fiscal-year basis. The Company ends its quarters on the Sunday closest to the end of the applicable calendar quarter, except in a 53-week fiscal year, in which case the additional week falls into the fourth quarter of that fiscal year. Fiscal 2016 has 52 weeks and Fiscal 2015 had 53 weeks. The second quarter of fiscal 2016 ended on July 3, 2016 and the second quarter of fiscal 2015 ended on June 28, 2015.

Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments of a normal, recurring nature, which are necessary to state fairly the financial information included therein. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in Cypress's Annual Report on Form 10-K for the fiscal year ended January 3, 2016. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.

On March 12, 2015, the Company completed the merger (“Merger”) with Spansion Inc. ("Spansion") pursuant to the Agreement and Plan of Merger and Reorganization, as of December 1, 2014 (the "Merger Agreement"), for a total consideration of approximately $2.8 billion. Consequently, the financial condition and results of operations includes the financial results of legacy Spansion beginning March 12, 2015.  The comparability of our results for the six months ended July 3, 2016 to the same periods in fiscal 2015 is significantly impacted by the Merger.

Certain balances included in the Condensed Consolidated Balance Sheet and Condensed Consolidated Statement of Cash Flows for prior periods have been reclassified to conform to the current period presentation.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

The condensed consolidated results of operations for the three and six months ended July 3, 2016 are not necessarily indicative of the results to be expected for the full fiscal year.

Summary of Significant Accounting Policies

Revenue Recognition

The Company has historically recognized a significant portion of revenue through distributors at the time the distributor resold the product to its end customer (also referred to as the sell-through basis of revenue recognition) given the difficulty in estimating the ultimate price of these product shipments and amount of potential returns. The Company continuously reassesses its ability to reliably estimate the ultimate price of these products and, over the past several years, has made investments in its systems and processes around its distribution channel to improve the quality of the information it receives from its distributors. Given these ongoing investments, and based on the financial framework we use for estimating potential price adjustments, in the fourth quarter of 2014 the Company began recognizing revenue on certain product families and with certain distributors (less its estimate of future price adjustments and returns) upon shipment to the distributors (also referred to as the sell-in basis of revenue recognition).  During the three months ended July 3, 2016, the Company recognized an incremental $24.2 million of revenue on additional product families for which revenue was previously recognized on a sell-through basis as it determined that it could reasonably estimate returns and pricing concessions at the time of shipment to distributors.  This change resulted in a reduction of the Company’s net loss of $6.8 million or $0.02 per basic and diluted share for the three months ended July 3, 2016.  During the three months ended June 28, 2015, there were no new product families or distributors for which the Company recognized revenue on a sell-in basis.

8


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

During the six months ended July 3, 2016, the Company recognized approximately $40.6 million of incremental revenue from this change in revenue recognition, which resulted in a reduction of the Company’s net loss of approximately $14.2 million for the six months ended July 3, 2016, or approximately $0.05 per basic and diluted share. During the six months ended June 28, 2015, the Company recognized approximately $22.7 million of incremental revenue from this change, which resulted in a benefit to net income of approximately $13.7 million for the six months ended June 28, 2015, or approximately $0.05 per basic and diluted share.  During the three months ended July 3, 2016, we recognized approximately $306.5 million or 92.8% of distribution revenue on a sell-in basis. During the three months ended June 28, 2015, we recognized approximately $220.7million or 62.5% of distribution revenue on a sell-in basis. During the six months ended July 3, 2016, the Company recognized approximately $540.0 million or 86.9% of distribution revenue on a sell-in basis. During the six months ended June 28, 2015, we recognized approximately $329.1 million or 51.1% of distribution revenue on a sell-in basis.

Net Loss per Share

Basic net loss per share is calculated by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method (by using the average stock price for the period to determine the number of shares assumed to be purchased from the exercise of stock options or warrants), and convertible debt, using the treasury stock method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive.

Convertible debt

In accounting for the Senior Exchangeable Notes at issuance, the Company separated the Notes into debt and equity components according to accounting standards codification ("ASC") 470-20 for convertible debt instruments that may be fully or partially settled in cash upon conversion. The carrying amount of the debt component, which approximates its fair value, was estimated by using an interest rate for nonconvertible debt, with terms similar to the Notes. The excess of the principal amount of the Notes over the fair value of the debt component was recorded as a debt discount and a corresponding increase in additional paid-in capital. The debt discount is accreted to the carrying value of the Notes over their term as interest expense using the effective interest method. In accounting for the transaction costs incurred relating to issuance of the Notes, the Company allocated the costs of the offering in proportion to the fair value of the debt and equity recognized in accordance with the accounting standards. The transaction costs allocated to the debt are being amortized as interest expense over the term of the Notes.

In accounting for the cost of the capped call transaction entered in connection with issuance of the Senior Exchangeable Notes, the Company included the cost as a net reduction to additional paid-in capital in the stockholders’ equity section of the consolidated balance sheet, in accordance with the guidance in ASC 815-40 Derivatives and Hedging-Contracts in Entity’s Own Equity.  See Note 8 for further details.

 

 

 

NOTE 2. GOODWILL

 

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. The Company has four reporting units of which two, Memory Products Division (MPD) and Programmable Systems Division (PSD), carried goodwill in the amounts of $770.0 million and $968.8 million respectively, as of January 3, 2016.

 

During the quarter ended July 3, 2016, the Company concluded that a combination of factors, including (a) decreases in our forecasted operating results when compared with the expectations of the PSD reporting unit at the time of the Merger, primarily in consumer markets as the Company has subsequently increased its focus on the automotive and industrial end markets, (b) evaluation of business priorities due to recent changes in management, and (c) certain market conditions necessitated a quantitative impairment analysis for the carrying value of the Goodwill related to PSD which resulted in an impairment charge of $488.5 million.  

 

As the first step of the quantitative test (“Step 1”), the Company estimated the fair value of the net assets, including goodwill related to PSD. In estimating these fair values, a combination of a market approach and an income approach was utilized. This combination was deemed to be the most indicative of the reporting unit’s estimated fair value in an orderly transaction between market participants and is consistent with the methodology of the Company used for the goodwill impairment tests in prior years. In performing the step 1 analysis in the second quarter of fiscal 2016, the Company applied a weighting of 75% to the income approach and 25% to the market approach. Under the market approach, the Company utilizes publicly-traded comparable company information

9


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

to determine revenue and earnings multiples that are used to value the reporting units. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit discounted by an estimated weighted-average cost of capital, reflecting the overall level of inherent risk of the reporting unit and the rate of return an outside investor would expect to earn. The Company based cash flow projections for PSD using a forecast of cash flows and a terminal value based on the industry’s perpetuity growth model. The forecast and related assumptions were derived from a recently completed five-year outlook which included adjustments arising from the changes in strategic decisions as discussed above.

 

Based on the Step 1 analysis, the Company concluded that the carrying value of PSD’s net assets exceeded their estimated fair value as of June 1, 2016, the date of the analysis.

 

The Company performed an analysis as required by ASC 350 and did not note an impairment in the carrying value of the long-lived assets related to PSD.

 

The deficiency between the carrying and estimated fair value of the net assets as noted in Step 1, required the second step of the quantitative test (“Step 2”) to be performed by comparing the carrying value of the goodwill related to PSD to its implied fair value. The implied fair value is calculated by allocating all of the assets and liabilities of the reporting unit, including any unrecognized intangible assets, in a hypothetical analysis that calculates the implied fair value of goodwill in the same manner as if the reporting unit was being acquired in a business combination. An impairment charge is recognized for the excess of the carrying value of goodwill over its implied fair value.

 

The Company has completed a preliminary assessment of the implied fair value of the PSD reporting unit, which resulted in a partial impairment of goodwill of $488.5 million. Due to the complexity and effort required to estimate the fair value of the reporting unit in the second step of the analysis, the fair value estimates were based on preliminary analysis and assumptions that are subject to change. The measurement of impairment will be completed in the third quarter of fiscal 2016 and further adjustments to the preliminary goodwill impairment charge, if any, may be recognized when the Company finalizes the second step of the goodwill impairment test.

 

Given the partial impairment recorded in the PSD reporting unit, it is reasonably possible that even small future changes in judgments, assumptions and estimates the Company made in assessing the implied fair value of goodwill could cause the Company to determine that some or all of the remaining goodwill of the PSD reporting unit has become impaired. In addition, a future decline in market conditions and/or changes in the Company’s market share could negatively impact the market comparables, estimated future cash flows and discount rates used in the market and income approaches to determine the fair value of the reporting unit and could result in another material impairment charge in the future.

 

During the six months ended July 3, 2016, the Company did not note any triggers that necessitated an impairment analysis for the MPD reporting unit.

The changes in the carrying amount of goodwill by reportable segment for the six months ended July 3, 2016 were as follows:

 

 

 

MPD

 

 

PSD

 

 

Total

 

 

 

(in thousands)

 

Goodwill as of January 3, 2016 (1)

 

$

770,046

 

 

$

968,836

 

 

$

1,738,882

 

Impairment

 

 

-

 

 

 

(488,504

)

 

 

(488,504

)

Goodwill as of July 3, 2016

 

$

770,046

 

 

$

480,332

 

 

$

1,250,378

 

 

(1)

The Company previously recorded an impairment charge of $351.3 million in the fourth quarter of fiscal 2008.

 

 

10


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

NOTE 3. INTANGIBLE ASSETS

The following table presents details of the Company's intangible assets:

 

 

 

As of July 3, 2016

 

 

As of January 3, 2016

 

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net (a)

 

 

Gross

 

 

Accumulated

Amortization

 

 

Net (a)

 

 

 

(In thousands)

 

Developed technology and other intangible assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition-related intangible assets

 

$

879,709

 

 

$

(294,210

)

 

$

585,499

 

 

$

836,256

 

 

$

(226,417

)

 

$

609,839

 

Non-acquisition related intangible assets

 

 

12,714

 

 

 

(10,367

)

 

 

2,347

 

 

 

13,368

 

 

 

(10,228

)

 

 

3,140

 

Total developed technology and other intangible

   assets

 

 

892,423

 

 

 

(304,577

)

 

 

587,846

 

 

 

849,624

 

 

 

(236,645

)

 

 

612,979

 

In-process research and development

 

 

99,039

 

 

 

 

 

 

99,039

 

 

 

176,216

 

 

 

 

 

 

176,216

 

Total intangible assets

 

$

991,462

 

 

$

(304,577

)

 

$

686,885

 

 

$

1,025,840

 

 

$

(236,645

)

 

$

789,195

 

 

 

(a)

Included in the intangible assets are in-process research and development projects acquired as part of the Merger (“IPR&D”) that had not attained technological feasibility and commercial production:

 

 

 

(in thousands)

 

As of January 3, 2016

 

$

176,216

 

Technological feasibility achieved

 

 

(43,233

)

Projects impaired

 

 

(33,944

)

As of July 3, 2016

 

$

99,039

 

 

In the first half of fiscal 2016, the Company recognized a $33.9 million impairment charge related to two IPR&D projects that were cancelled due to changes in the Company’s product portfolio strategy.  The impairment charges are included in the “Impairment of acquisition-related intangible assets” line in the Condensed Consolidated Statements of Operations.

 

The Company expects the remaining IPR&D projects as of July 3, 2016 to attain technological feasibility by the first half of fiscal 2017.

The estimated future amortization expense related to developed technology and other intangible assets as of July 3, 2016 is as follows:

 

 

 

(In thousands)

 

2016 (remaining six months)

 

$

65,820

 

2017

 

 

130,986

 

2018

 

 

128,440

 

2019

 

 

121,212

 

2020

 

 

85,886

 

2021 and future

 

 

55,502

 

Total future amortization expense

 

$

587,846

 

 

 

NOTE 4. BALANCE SHEET COMPONENTS

Accounts Receivable, Net

 

 

 

As of

 

 

 

July 3,

2016

 

 

January 3,

2016

 

 

 

(In thousands)

 

Accounts receivable, gross

 

$

328,635

 

 

$

295,803

 

Allowance for doubtful accounts receivable and sales returns

 

 

(3,493

)

 

 

(3,067

)

Total accounts receivable, net

 

$

325,142

 

 

$

292,736

 

11


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

 

Inventories

 

 

 

As of

 

 

 

July 3,

2016

 

 

January 3,

2016

 

 

 

(In thousands)

 

Raw materials

 

$

15,430

 

 

$

13,516

 

Work-in-process

 

 

161,494

 

 

 

192,245

 

Finished goods

 

 

43,966

 

 

 

37,834

 

Total inventories

 

$

220,890

 

 

$

243,595

 

 

Other Current Assets

 

 

 

As of

 

 

 

July 3,

2016

 

 

January 3,

2016

 

 

 

(In thousands)

 

Prepaid tooling assets

 

$

20,771

 

 

$

19,379

 

Restricted cash relating to defined benefit pension plan, current

 

 

4,181

 

 

 

3,730

 

Foundry service prepayments - current portion

 

 

5,903

 

 

 

5,753

 

Advances to suppliers

 

 

10,844

 

 

 

10,683

 

Prepaid royalty and licenses

 

 

19,975

 

 

 

14,281

 

Derivative Asset

 

 

11,317

 

 

 

966

 

Value added tax receivable

 

 

16,867

 

 

 

12,493

 

Receivable from sale of TrueTouch Mobile®business

 

 

10,000

 

 

 

 

Other current assets

 

 

27,812

 

 

 

19,595

 

Total other current assets

 

$

127,670

 

 

$

86,880

 

 

Other Long-term Assets

 

 

 

As of

 

 

 

July 3,

2016

 

 

January 3,

2016

 

 

 

(In thousands)

 

Employee deferred compensation plan

 

$

40,030

 

 

$

41,249

 

Investments in equity securities

 

 

61,121

 

 

 

57,030

 

Deferred tax assets

 

 

4,199

 

 

 

4,080

 

Long-term license

 

 

25,793

 

 

 

24,079

 

Restricted cash relating to defined benefit pension plan, non current

 

 

4,377

 

 

 

3,462

 

Long-term receivable from sale of TrueTouch Mobile®business

 

 

 

 

 

10,000

 

Foundry service prepayments - non-current portion

 

 

30,976

 

 

 

26,237

 

Other assets

 

 

34,621

 

 

 

34,272

 

Total other long-term assets

 

$

201,117

 

 

$

200,409

 

 

12


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

Other Current Liabilities

 

 

 

As of

 

 

 

July 3,

2016

 

 

January 3,

2016

 

 

 

(In thousands)

 

Employee deferred compensation plan

 

$

40,941

 

 

$

41,457

 

Restructuring accrual  - current portion (See Note 5)

 

 

4,642

 

 

 

7,270

 

Deferred revenue on sale of True Touch mobile® business

 

 

5,789

 

 

 

15,295

 

Rebate reserve

 

 

10,236

 

 

 

7,944

 

Derivative liability

 

 

10,358

 

 

 

1,283

 

Other current liabilities

 

 

55,347

 

 

 

76,444

 

Total other current liabilities

 

$

127,313

 

 

$

149,693

 

 

Other Long-term Liabilities

 

 

 

As of

 

 

 

July 3,

2016

 

 

January 3,

2016

 

 

 

(In thousands)

 

Long-term defined benefit pension plan liabilities

 

$

4,935

 

 

$

8,712

 

Restructuring accrual - non-current portion (See Note 5)

 

 

12,654

 

 

 

14,217

 

Asset retirement obligation

 

 

5,024

 

 

 

2,783

 

Other long-term liabilities

 

 

18,550

 

 

 

12,072

 

Total other long-term liabilities

 

$

41,163

 

 

$

37,784

 

 

 

NOTE 5. RESTRUCTURING

Spansion Integration-Related Restructuring Plan

In March 2015, the Company began the implementation of planned cost reduction and restructuring activities in connection with the Merger.

The following table summarizes the restructuring charges recorded in the Company’s Condensed Consolidated Statements of Operations for the periods presented pursuant to the Spansion Integration-Related Restructuring Plan:

 

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3,

2016

 

 

June 28,

2015

 

 

July 3,

2016

 

 

June 28,

2015

 

 

 

(In thousands)

 

Personnel costs

 

$

369

 

 

$

11,120

 

 

$

615

 

 

$

55,326

 

Lease termination costs and other related charges

 

 

285

 

 

 

(845

)

 

 

309

 

 

 

17,897

 

Impairment of property, plant and equipment

 

 

 

 

 

(236

)

 

 

 

 

 

12,531

 

Total restructuring costs

 

$

654

 

 

$

10,039

 

 

$

924

 

 

$

85,754

 

 

All restructuring costs are included in Costs and expenses under "Restructuring costs" in the Condensed Consolidated Statements of Operations.

13


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

Restructuring activity under the Spansion Integration – Related Restructuring Plan during the six months ended July 3, 2016 was as follows:

 

 

 

Six Months Ended

 

 

 

July 3,

2016

 

 

 

(In thousands)

 

Accrued restructuring balance as of January 3, 2016

 

$

21,487

 

Provision

 

 

270

 

Cash payments and other adjustments

 

 

(3,028

)

Accrued restructuring balance as of April 3, 2016

 

$

18,729

 

Provision

 

$

654

 

Cash payments and other

 

 

(2,087

)

Accrued restructuring balance as of July 3, 2016

 

$

17,296

 

Current portion of the restructuring accrual

 

$

4,642

 

Non-current portion of the restructuring accrual

 

$

12,654

 

 

The Company anticipates that the remaining restructuring accrual balance will be paid out in cash through the remainder of 2016 for employee terminations and over the remaining lease term through 2026 for the excess lease obligation related to the buildings Spansion had leased prior to the Merger, which the Company decided not to occupy in the post-Merger period.

 

 

14


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

NOTE 6. FAIR VALUE MEASUREMENTS

Assets/Liabilities Measured at Fair Value on a Recurring Basis

The following tables present the fair value hierarchy for the Company's financial assets and liabilities measured at fair value on a recurring basis and its non-financial liabilities measured at fair value on a non-recurring basis as of July 3, 2016 and January 3, 2016:

 

 

 

As of July 3, 2016

 

 

As of January 3, 2016

 

 

 

Level 1

 

 

Level 2

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Total

 

 

 

(In thousands)

 

Financial Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds  (1)

 

$

116

 

 

$

 

 

$

116

 

 

$

119

 

 

$

 

 

$

119

 

Total cash equivalents

 

 

116

 

 

 

 

 

 

116

 

 

 

119

 

 

 

 

 

 

119

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Certificates of deposit (1)

 

 

 

 

 

 

970

 

 

 

970

 

 

 

 

 

 

871

 

 

 

871

 

Total short-term investments

 

 

 

 

 

970

 

 

 

970

 

 

 

 

 

 

871

 

 

 

871

 

Long-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable equity securities

 

 

1,587

 

 

 

 

 

 

1,587

 

 

 

6,516

 

 

 

 

 

 

6,516

 

Total long-term investments

 

 

1,587

 

 

 

 

 

 

1,587

 

 

 

6,516

 

 

 

 

 

 

6,516

 

Employee deferred compensation plan assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

3,755

 

 

 

 

 

 

3,755

 

 

 

3,333

 

 

 

 

 

 

3,333

 

Mutual funds

 

 

21,927

 

 

 

 

 

 

21,927

 

 

 

22,023

 

 

 

 

 

 

22,023

 

Equity securities

 

 

8,179

 

 

 

 

 

 

8,179

 

 

 

8,624

 

 

 

 

 

 

8,624

 

Fixed income

 

 

 

 

 

3,243

 

 

 

3,243

 

 

 

 

 

 

3,227

 

 

 

3,227

 

Money market funds

 

 

2,926

 

 

 

 

 

 

2,926

 

 

 

4,042

 

 

 

 

 

 

4,042

 

Total employee deferred compensation plan

   assets

 

 

36,787

 

 

 

3,243

 

 

 

40,030

 

 

 

38,022

 

 

 

3,227

 

 

 

41,249

 

Foreign exchange forward contracts

 

 

 

 

 

11,317

 

 

 

11,317

 

 

 

 

 

 

966

 

 

 

966

 

Total financial assets

 

$

38,490

 

 

$

15,530

 

 

$

54,020

 

 

$

44,657

 

 

$

5,064

 

 

$

49,721

 

Financial Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange forward contracts

 

$

 

 

$

10,358

 

 

$

10,358

 

 

$

 

 

$

1,283

 

 

$

1,283

 

Employee deferred compensation plan liability

 

 

 

 

 

40,941

 

 

 

40,941

 

 

 

 

 

 

41,457

 

 

 

41,457

 

Total financial liabilities

 

$

 

 

$

51,299

 

 

$

51,299

 

 

$

 

 

$

42,740

 

 

$

42,740

 

 

 

(1)

Available for sale securities, maturing within one year.  There were no unrealized gains or losses recorded during the three and six months ended July 3, 2016 and June 28, 2015 related to these securities.

The Company did not have any assets or liabilities measured at fair value using level 3 inputs as of July 3, 2016 and January 3, 2016.  There were no transfers between Level 1, Level 2 and Level 3 fair value hierarchies during the six months ended July 3, 2016.

Valuation Techniques:

There have been no changes to the valuation techniques used to measure the fair value of the Company's assets and liabilities. For a description of the valuation techniques, refer to Note 5 of the Notes to the Consolidated Financial Statements included in the Company's Annual report on Form 10-K for the year ended January 3, 2016.

 

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

Certain of the Company’s assets, including Intangible Assets and Goodwill are carried at historical cost but are remeasured on a non-recurring basis and are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment).  For the six months ended July 3, 2016, the Company recorded a $33.9 million impairment charge related to two IPR&D projects acquired in the Merger. During the same period the Company recorded a $488.5 million goodwill impairment charge related to PSD reporting unit based on a fair value measurement that included level 3 inputs. There were no impairment charges recorded for the three and six months ended June 28, 2015.

15


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

As of July 3, 2016, the carrying value of the Company's Revolving Credit Facility was $367.0 million (See Note 8). The carrying value of the Company's Credit Facility approximates its fair value since it bears an interest rate that is comparable to rates on similar credit facilities and is determined using level 2 inputs.

The Company's 2.00% Senior Exchangeable Notes assumed as part of the Merger are traded in the market and are categorized as a Level 2 liability. The carrying value and the estimated fair value of the said Notes as of July 3, 2016 were $133.6 million and $303.4 million, respectively.  See Note 8 for further details.

The Company’s 4.50% Senior Convertible Notes are traded in the secondary market and the fair value is determined using Level 2 inputs.  The carrying value and the estimated fair value of the debt portion of the said Notes as of July 3, 2016 were $231.5 million and $320.4 million, respectively.  See Note 8 for further details.

Investments in Equity Securities

The Company's investments in equity securities include long-term investments in non-marketable equity securities of privately-held companies valued at approximately $59.5 million and $50.5 million as of July 3, 2016 and January 3, 2016, respectively.

Included in the Company's non-marketable equity securities recorded within “Other long-term assets” line item of the Condensed Consolidated Balance Sheet is an investment in a company that designs, develops and manufactures certain battery storage products for mobile consumer devices.  This investment is being accounted for using the equity method. During the three and six months ended July 3, 2016, the Company invested an additional $7.0 million and $12.0 million, respectively, in this battery products company, which increased the Company’s cumulative total investment to $68.5 million.  This represented 42.5% of the investee's outstanding voting shares as of July 3, 2016. The Company held 38.7% of this investee’s voting shares as of January 3, 2016.

 

In the second quarter of fiscal 2016, the Company partially sold shares of its investments in Hua Hong Semiconductor Limited (HHSL), a publicly traded company, which is the parent company of Grace Semiconductor Manufacturing Corporation, one of the Company's strategic foundry partners, resulting in cash proceeds of approximately $4.3 million. The loss on the sale of said investment was not material.

The remaining privately-held equity investments are accounted for under the cost method and are periodically reviewed for other-than-temporary declines in fair value.

 

 

NOTE 7. EMPLOYEE STOCK PLANS AND STOCK-BASED COMPENSATION

The Company's equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests.

The following table summarizes the stock-based compensation expense by line item recorded in the Condensed Consolidated Statements of Operations:

 

 

 

Three Months Ended

 

 

Six months ended

 

 

 

July 3,

2016

 

 

June 28,

2015

 

 

July 3,

2016

 

 

June 28,

2015

 

 

 

(In thousands)

 

Cost of revenues

 

$

4,278

 

 

$

3,910

 

 

$

9,925

 

 

$

8,631

 

Research and development

 

 

5,329

 

 

 

6,908

 

 

 

12,259

 

 

 

12,661

 

Selling, general and administrative

 

 

9,242

 

 

 

16,849

 

 

 

20,203

 

 

 

25,172

 

Total stock-based compensation expense

 

$

18,849

 

 

$

27,667

 

 

$

42,387

 

 

$

46,464

 

 

As of July 3, 2016 and January 3, 2016, stock-based compensation capitalized in inventories totaled $4.0 million and $4.3 million, respectively.

16


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

The following table summarizes the stock-based compensation expense by type of awards:

 

 

 

Three Months Ended

 

 

Six months ended

 

 

 

July 3,

2016

 

 

June 28,

2015

 

 

July 3,

2016

 

 

June 28,

2015

 

 

 

(In thousands)

 

Stock options

 

$

206

 

 

$

572

 

 

$

504

 

 

$

1,268

 

Restricted stock units ("RSUs"), including Performance-Based

   Restricted Stock Units ("PSUs")

 

 

13,204

 

 

 

23,882

 

 

 

30,597

 

 

 

38,770

 

Employee Stock Purchase Plan (“ESPP”)

 

 

5,439

 

 

 

3,213

 

 

 

11,286

 

 

 

6,426

 

Total stock-based compensation expense

 

$

18,849

 

 

$

27,667

 

 

$

42,387

 

 

$

46,464

 

 

The following table summarizes the unrecognized stock-based compensation expense, net of estimated forfeitures, by type of awards:

 

 

 

As of

 

 

 

July 3,

2016

 

 

Weighted-

Average

Amortization

Period

 

 

 

(In thousands)

 

 

(In years)

 

Stock options

 

$

1,481

 

 

 

1.02

 

RSUs including PSUs

 

 

59,244

 

 

 

1.38

 

ESPP

 

 

7,475

 

 

 

0.54

 

Total unrecognized stock-based compensation expense

 

$

68,200

 

 

 

1.28

 

 

During the three months ended July 3, 2016, the Company, as part of the severance agreement executed with Dr. T.J. Rodgers, accelerated the vesting of the PSU’s previously granted and modified the vesting conditions such that 100% of such awards vested on the effective date of his termination which was April 28, 2016.  Included in the stock-based compensation expense for the three and six months ended July 3, 2016, is an amount of $3.1 million related to the impact of the said modification.

Equity Incentive Program

As of July 3, 2016, approximately 31.9 million stock options, or 21.8 million RSUs/PSUs were available for grant as share based awards under the 2013 Stock Plan, the 2010 Equity Incentive Award Plan (formerly the Spansion 2010 Equity Incentive Award Plan) and the 2012 Incentive Award Plan (formerly the Ramtron Plan).  As of July 3, 2016, there were 2.6 million shares of stock available for issuance under the ESPP plan.

Stock Options

The following table summarizes the Company's stock option activities:

 

 

 

Shares

 

 

Weighted-

Average

Exercise

Price Per

Share

 

 

Weighted Average Remaining Contractual term

 

 

Aggregate Intrinsic Value

 

 

 

(In thousands, except

per-share amounts)

 

 

(In years)

 

 

($ in millions)

 

Options outstanding as of January 3, 2016

 

 

16,840

 

 

$

7.99

 

 

 

 

 

 

 

 

 

Exercised

 

 

(191

)

 

$

4.19

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(163

)

 

$

11.35

 

 

 

 

 

 

 

 

 

Options outstanding as of April 3, 2016

 

 

16,486

 

 

$

8.00

 

 

 

 

 

 

 

 

 

Exercised

 

 

(7,069

)

 

$

4.85

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(97

)

 

$

12.88

 

 

 

 

 

 

 

 

 

Options outstanding as of July 3, 2016

 

 

9,320

 

 

$

10.35

 

 

 

3.39

 

 

$

14.60

 

Options exercisable as of July 3, 2016

 

 

7,483

 

 

$

10.11

 

 

 

3.05

 

 

$

14.27

 

17


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

 

There were no options granted for the three and six months ended July 3, 2016.

Restricted Stock Units (“RSUs”) and Performance-Based Restricted Stock Units (“PSUs”)

The following table summarizes the Company's RSU/PSU activities:

 

 

 

Shares

 

 

Weighted-

Average

Grant

Date Fair

Value Per

Share

 

 

 

(In thousands, except

per-share amounts)

 

Balance as of January 3, 2016

 

 

11,053

 

 

$

13.43

 

Granted

 

 

1,957

 

 

$

10.97

 

Vested

 

 

(2,903

)

 

$

14.53

 

Forfeited

 

 

(1,304

)

 

$

12.66

 

Balance as of April 3, 2016

 

 

8,803

 

 

$

12.63

 

Granted

 

 

1,316

 

 

$

9.31

 

Released

 

 

(1,073

)

 

$

12.56

 

Forfeited

 

 

(199

)

 

$

12.17

 

Balance as of July 3, 2016

 

 

8,847

 

 

$

12.16

 

 

On April 1, 2016, the Compensation Committee of the Company approved the grant of 0.9 million awards of restricted stock units to certain of the Company’s executive officers (the “2016 Grants”). Approximately 57% of the 2016 Grants are in the form of PSUs which vest based on achievement of two performance milestones: product development and production milestones and Gross Margin goals—over the next two years.  Such PSU grants will be capped at target levels if Cypress’s total shareholder return (TSR) is negative, even if the Product Development/Production or Gross Margin performance milestones are achieved at above-target or maximum levels. The remaining 43% of the 2016 Grants are in the form of RSUs which cliff vest based on continued service over two years.

In addition to PSUs subject to the milestones specified above, a portion of the grants under the 2015 performance based restricted stock (“PARS”) Program are RSUs which have service-based vesting terms under which employees are eligible to earn 100% of their RSUs if they remain an employee of the Company through specified dates between fiscal 2016 and 2018.

 

 

 

18


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

NOTE 8. DEBT

 

Total debt is comprised of the following:

 

 

 

As of

 

 

 

July 3, 2016

 

 

January 3, 2016

 

 

 

(In thousands)

 

Current portion of long-term debt

 

 

 

 

 

 

 

 

Capital lease obligations

 

$

5,675

 

 

$

6,603

 

Equipment loans

 

 

1,511

 

 

 

3,003

 

Term Loan A

 

 

6,250

 

 

 

5,000

 

Current portion of long-term debt

 

 

13,436

 

 

 

14,606

 

Revolving credit facility and long-term debt

 

 

 

 

 

 

 

 

Senior Secured Credit facility

 

 

367,000

 

 

 

449,000

 

Term Loan A

 

 

88,301

 

 

 

92,228

 

2.00% Senior Exchangeable Notes

 

 

133,607

 

 

 

131,845

 

4.50% Senior Exchangeable Notes

 

 

231,456

 

 

 

 

Capital lease obligations

 

 

 

 

 

586

 

Revolving credit facility and long-term debt

 

 

820,364

 

 

 

673,659

 

Total debt

 

$

833,800

 

 

$

688,265

 

 

4.50% Senior Exchangeable Notes

 

On June 23, 2016, the Company, issued at face value, $287.5 million of Senior Exchangeable Notes due 2022 (the “Notes”) in a private placement to qualified institutional buyers under Rule 144A of the Securities Act of 1933, as amended. The Notes are governed by an Indenture (“Indenture”), dated June 23, 2016, between the Company and U.S. Bank National Association, as Trustee. The Notes will mature on January 15, 2022, unless earlier repurchased or converted, and bear interest of 4.50% per year payable semi-annually in arrears on January 15 and July 15, commencing on January 15, 2017. The Notes may be due and payable immediately in certain events of default.

 

The Notes are exchangeable for an initial exchange rate of 74.1372 shares of common stock per $1,000 principal amount of the Notes (equivalent to an initial exchange price of approximately $13.49 per share) subject to adjustments for anti-dilutive issuances and make-whole adjustments upon a fundamental change. A fundamental change includes a change in control, delisting of the Company’s stock and liquidation, consolidation or merger of the Company. Prior to October 15, 2021, the Notes will be exchangeable under certain specified circumstances as described in the Indenture.  On or after October 15, 2021, until the close of business on the second scheduled trading day immediately preceding the maturity date, the Notes will be convertible in multiples of $1,000 principal amount regardless of the foregoing circumstances.  

 

Upon conversion, the Company may pay or deliver, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at its election. If the Company satisfies its conversion obligation solely in cash or through payment and delivery, as the case may be, of a combination of cash and shares of its common stock, the amount of cash and shares of common stock, if any, due upon conversion will be based on a pre-defined conversion value.

 

It is the Company’s intent that upon conversion, the Company would pay the holders of the Notes cash for an amount up to the aggregate principal the Notes. If the conversion value exceeds the principal amount, the Company intends to deliver shares of its common stock in respect to the remainder of its conversion obligation in excess of the aggregate principal amount (“conversion spread”). Accordingly, for the purposes of calculating diluted earnings per share, there would be no adjustment to the numerator in the net income per common share computation for the cash settled portion of the Notes, as that portion of the debt liability is expected to be settled in cash. The conversion spread, will be included in the denominator for the computation of diluted net income per common share, using the treasury stock method.

 

In accordance with ASC 470-20, Debt with Conversion and Other Options, the Company separated the Convertible Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the estimated fair value of a similar liability that does not have an associated convertible feature. Such amount was based on the contractual cash flows discounted at an appropriate market rate for non-convertible debt at the date of issuance, which was determined to be 82.9% of the par

19


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

value of the Notes or $238.3 million. The carrying amount of the equity component of $49.2 million representing the conversion option was determined by deducting the fair value of the liability component from the face value of the Convertible Notes as a whole. The excess of the principal amount of the liability component over its carrying amount ("debt discount") is accreted to interest expense over the term of the Notes using the effective interest method. The equity component is not re-measured as long as it continues to meet the conditions for equity classification.

 

The Company incurred transaction costs of approximately $8.63 million relating to the issuance of the Notes.  The transaction costs of $8.63 million include $7.91 million financing fees paid to the initial purchases of The Notes, and other estimated offering expenses payable by the Company. In accounting for these costs, the Company allocated the costs of the offering in proportion to the fair value of the debt and equity recognized in accordance with the accounting standards. The transaction costs allocated to the debt component of approximately $7.2 million and are being amortized as interest expense over the term of the Notes using the effective yield method. The transaction costs allocated to the equity component of approximately $1.5 million were recorded as a reduction of additional paid-in capital.  

 

At the debt issuance date, the Convertible Notes, net of issuance costs, consisted of the following (in thousands):

 

 

 

June 23, 2016

 

Liability component

 

 

 

 

Principal

 

 

238,338

 

Less: Issuance cost

 

 

(7,158

)

Net carrying amount

 

 

231,180

 

Equity component

 

 

 

 

Allocated amount

 

 

49,163

 

Less: Issuance cost

 

 

(1,477

)

Net carrying amount

 

 

47,686

 

Convertible Notes, net of issuance costs

 

 

278,866

 

 

The following table includes total interest expense related to the Notes recognized for during the three and six months ended July 3, 2016 (in thousands):

 

 

 

Three and Six months ended July 3, 2016

 

Contractual interest expense

 

$

354

 

Amortization of debt issuance costs

 

 

34

 

Accretion of debt discount

 

 

242

 

Total

 

$

630

 

 

The net liability component of Notes as of July 3, 2016 is comprised of the following (in thousands):

 

 

 

July 3, 2016

 

Net carrying amount at issuance date

 

$

231,180

 

Amortization of debt issuance costs during the year

 

 

34

 

Accretion of debt discount during the year

 

 

242

 

 

 

$

231,456

 

 

Capped Calls

 

In connection with the issuance of the Notes, the Company entered into capped call transactions with certain bank counterparties to reduce the risk of potential dilution of the Company’s common stock upon the exchange of the Notes. The capped call transactions have a strike price of approximately $13.49 and a cap price of approximately $15.27, and are exercisable when and if the Notes are converted. If upon conversion of the Convertible Notes, the price of the Company’s common stock is above the strike price of the capped calls, the counterparties will deliver shares of the Company’s common stock and/or cash with an aggregate value approximately equal to the difference between the price of the Company’s common stock at the conversion date (as defined, with a maximum price for purposes of this calculation equal to the cap price) and the strike price, multiplied by the number of shares of the

20


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

Company’s common stock related to the capped call transactions being exercised. The capped calls expire in January 2022. The Company paid $8.2 million for these capped calls which were recorded as a reduction in additional paid-in capital.

 

Senior Secured Revolving Credit Facility

On April 27, 2016, the Company amended and restated its existing senior secured revolving credit facility ("Credit Facility") and of $540 million. The borrowings under the Credit Facility bear interest, at the Company's option, at an adjusted base rate plus a spread of 1.25%, or an adjusted LIBOR rate plus a spread of 2.25%. The borrowings under the Credit Facility are guaranteed by certain present and future wholly-owned material domestic subsidiaries of the Company (the “Guarantors”) and secured by a security interest in substantially all assets of the Company and the Guarantors. The financial covenants include the following conditions: 1) maximum total leverage ratio of 4.50x through October 2016, 4.25x until January 1, 2017, 4.00 x until April 2, 2017 and 3.75x thereafter, 2) minimum fixed charge coverage ratio of 1.00x. The Company incurred financing costs of $2.6 million related to the Credit Facility which has been capitalized and recognized in other long-term assets on the Condensed Consolidated Balance Sheet. These costs will be amortized over the life of the Credit Facility and recorded in “Interest Expense” on the Condensed Consolidated Statement of Operations.

 

As per the terms of the Credit Facility, the Company entered into a Joinder Agreement on December 22, 2015 under which the Company borrowed an additional $100 million (“Term Loan A”). Term Loan A is subject to, at the Company’s option, either an interest rate equal to (i) 3.25% over LIBOR or (ii) an interest rate equal to 2.25% over the greater of (x) the prime lending rate published by the Wall Street Journal, (y) the federal funds effective rate plus 0.50%, and (z) the LIBOR rate for a one month interest period plus 1%. The Company paid a 1.00% upfront fee in connection with the Term Loan A. Such Term Loan A is payable in quarterly installments equal to 1.25% of the principal per quarter for 2016, 1.875% of the principal per quarter for 2017 and 2018, and 2.50% of the principal per quarter thereafter, with the remaining outstanding principle amount due at final maturity on March 12, 2020. It may be voluntarily prepaid at the Company’s option and is subject to mandatory prepayments equal to (i) 50% of excess cash flow, as defined in the agreement, (stepping down to 25% and 0% based on a decrease in total leverage ratio over time) at the end of each fiscal year, (ii) the net cash proceeds from certain asset sales (subject to certain reinvestment rights) and (iii) the proceeds from any debt issuances not otherwise permitted under the Credit Agreement. The Company incurred financing costs of $2.8 million to the lenders of Term Loan A which has been capitalized and recognized as a deduction of the Term Loan A balance in “Long-term revolving credit facility and long term debt” on the Consolidated Balance Sheet. These costs will be amortized over the life of Term Loan A and recorded in “Interest Expense” on the Condensed Consolidated Statement of Operations.

 

As of July 3, 2016, $464.5 million aggregate principal amount of loans, including Term Loan A, were outstanding under the Credit Facility.

As of July 3, 2016, the Company was in compliance with all of the financial covenants under the Credit Facility.

2.00% Senior Exchangeable Notes

Pursuant to the Merger, Cypress assumed Spansion's 2.00% Senior Exchangeable Notes (the “Assumed Notes”) on March 12, 2015. They are fully and unconditionally guaranteed on a senior unsecured basis by the Company. The Assumed Notes will mature on September 1, 2020, unless earlier repurchased or converted, and bear interest of 2.00% per year payable semi-annually in arrears on March 1 and September 1. The Assumed Notes may be due and payable immediately in certain events of default.

As of July 3, 2016, the Assumed Notes are exchangeable for 188.5 shares of common stock per $1,000 principal amount of the Notes (equivalent to an exchange price of approximately $5.31) subject to adjustments for dividends, anti-dilutive issuances and make-whole adjustments upon a fundamental change. A fundamental change includes a change in control, delisting of the Company’s stock and liquidation, consolidation or merger of the Company. According to the Indenture, a change in control occurs when a person or group becomes the beneficial owner directly or indirectly, of more than 50% of the Company’s common stock. In the case of a consolidation or merger, if the surviving entity continues to be listed, no change of control will be triggered. Prior to June 1, 2020, the Assumed Notes will be exchangeable under certain specified circumstances as described in the Indenture.

Upon conversion, the Company may pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of its common stock, at its election. If the Company satisfies its conversion obligation solely in cash or through payment and delivery, as the case may be, of a combination of cash and shares of our common stock, the amount of cash and shares of common stock, if any, due upon conversion will be based on a pre-defined conversion value.

21


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

It is Company’s intent that upon conversion, the Company would pay the holders of the Notes cash for an amount up to the aggregate principal the Notes. If the conversion value exceeds the principal amount, the Company intends to deliver shares of its common stock in respect to the remainder of its conversion obligation in excess of the aggregate principal amount (“conversion spread”). Accordingly, for the purposes of calculation of diluted earnings per share, there would be no adjustment to the numerator in the net income per common share computation for the cash settled portion of the Notes, as that portion of the debt liability is expected to be settled in cash. The conversion spread, will be included in the denominator for the computation of diluted net income per common share, using the treasury stock method.

The net carrying amount of the liability component of the Assumed Notes as of July 3, 2016 consists of the following:

 

 

 

(in thousands)

 

Principal amount

 

$

149,990

 

Unamortized debt discount

 

 

(16,383

)

Net carrying value

 

$

133,607

 

 

The following table presents the interest on the Assumed Notes recognized as an expense during the three and months ended July 3, 2016 and June 28, 2015:

 

 

 

Three Months

Ended

 

 

Six Months

Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(in thousands)

 

2.00% Senior Exchangeable Notes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contractual interest expense at 2% per annum

 

$

742

 

 

$

742

 

 

$

1,489

 

 

$

889

 

Accretion of debt discount

 

 

890

 

 

 

820

 

 

 

1,762

 

 

 

983

 

Total

 

$

1,632

 

 

$

1,562

 

 

$

3,251

 

 

$

1,872

 

Equipment Loans

In December 2011, the Company obtained equipment loans from a financial institution for an aggregate amount of approximately $14.1 million which are collateralized by certain manufacturing equipment and bear interest of 3.15% to 3.18% per annum payable in 60 equal installments.  The balance of $1.5 million outstanding against these loans as of July 3, 2016 is payable within the remaining six months of fiscal 2016.

Capital Leases

In 2011, the Company entered into capital lease agreements which allow it to borrow up to $35.0 million to finance the acquisition of certain manufacturing equipment. Assets purchased under all capital leases are included in “Property, plant and equipment, net” on the Company's Condensed Consolidated Balance Sheet.

As of July 3, 2016, the gross value and net book value of manufacturing equipment purchased under these capital leases were $11.1 million and $5.5 million, respectively.  As of January 3, 2016, the gross value and net book value of manufacturing equipment purchased under these capital leases were $20.5 million and $11.9 million, respectively.

22


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

Future Debt Payments

For each of the next five years and beyond, the scheduled maturities of the Company's debt including interest as of July 3, 2016, are as follows:

 

Fiscal Year

 

Term Loan A

 

 

Senior Secured Credit Facility

 

 

2.00% Senior Exchangeable Notes

 

 

4.50% Senior Exchangeable Notes

 

 

Capital lease obligations and Equipment loans

 

 

Total

 

 

 

(In thousands)

 

2016 (remaining

   six months)

 

$

3,988

 

 

$

5,046

 

 

$

1,500

 

 

$

 

 

$

7,243

 

 

$

17,777

 

2017

 

 

13,131

 

 

 

10,093

 

 

 

3,000

 

 

 

13,717

 

 

 

 

 

$

39,941

 

2018

 

 

12,673

 

 

 

10,093

 

 

 

3,000

 

 

 

12,938

 

 

 

 

 

$

38,704

 

2019

 

 

14,657

 

 

 

10,093

 

 

 

3,000

 

 

 

12,938

 

 

 

 

 

$

40,688

 

2020 and after

 

 

71,069

 

 

 

369,523

 

 

 

152,990

 

 

 

319,930

 

 

 

 

 

$

913,512

 

Total

 

$

115,518

 

 

$

404,848

 

 

$

163,490

 

 

$

359,523

 

 

$

7,243

 

 

$

1,050,622

 

 

 

NOTE 9. EQUITY TRANSACTIONS

$450 Million Stock Buyback Program

 

On October 20, 2015, the Company entered into a new $450 million stock buyback program (“October 2015 program”). The program allows the Company to purchase its common stock or enter into equity derivative transactions related to our common stock. The timing and actual amount expended with the new authorized funds will depend on a variety of factors including the market price of the Company’s common stock, regulatory, legal, and contractual requirements, alternatives uses of cash, availability of on-shore cash and other market factors. The October 2015 program does not obligate the Company to repurchase any particular amount of common stock and may be modified or suspended at any time at the Company’s discretion. Through the end of second quarter of fiscal 2016, the Company has repurchased a total of 29.5 million shares for a total cost of $239.0 million under the October 2015 program. Of this, 23.8 million shares worth $182.5 million were repurchased in the three and six months ended July 3, 2016, which includes withholdings for tax obligations on vested stock-based awards.

Dividends

On May 11, 2016 the Company's Board of Directors approved a cash dividend of $0.11 per share payable to holders of record of its common stock at the close of business day on June 30, 2016. This cash dividend was paid on July 21, 2016 and totaled approximately $35.2 million which was accrued for and shown as “Dividends payable” on the Condensed Consolidated Balance Sheet as of July 3, 2016.

 

For US income tax purposes, the Company will make a determination as to whether 2016 distributions are to be treated as a return of capital or a dividend after the Company's 2016 fiscal year end. At this time the Company anticipates that 2016 distributions will be taxable dividends and should be treated accordingly by dividend recipients until a final determination can be made. The Company’s distribution policy and the payment of cash distributions under that policy are subject to the Board's continuing determination that the distribution policy and the declaration of dividends are in the best interests of the Company’s stockholders and are in compliance with all laws and agreements of the Company applicable to the declaration and payment of cash distributions. This policy may be changed or cancelled in the Company’s discretion at any time.

 

 

NOTE 10. COMMITMENTS AND CONTINGENCIES

Operating Lease Commitments

The Company leases certain facilities and equipment under non-cancelable operating lease agreements that expire at various dates through fiscal 2020. Some leases include renewal options, which would permit extensions of the expiration dates at rates approximating fair market rental values at the time of the extension.

23


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

As of July 3, 2016, future minimum lease payments under non-cancelable operating leases were as follows:

 

Fiscal Year

 

(In thousands)

 

2016 (remaining six months)

 

$

9,406

 

2017

 

 

17,412

 

2018

 

 

11,308

 

2019

 

 

7,455

 

2020

 

 

6,699

 

2021 and thereafter

 

 

24,767

 

Total

 

$

77,047

 

 

Restructuring reserve balances related to operating facility leases were $15.7 million and $17.4 million as of July 3, 2016 and January 3, 2016, respectively.

Product Warranties

The Company generally warrants its products against defects in materials and workmanship for a period of one year and that product warranty is generally limited to a refund of the original purchase price of the product or a replacement part. The Company estimates its warranty costs based upon its historical warranty claim experience. Warranty returns are recorded as an allowance for sales returns. The allowance for sales returns is reviewed quarterly to verify that it properly reflects the remaining obligations based on the anticipated returns over the balance of the obligation period.

The following table presents the Company's warranty reserve activities:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3,

2016

 

 

June 28,

2015

 

 

July 3,

2016

 

 

June 28,

2015

 

 

 

(In thousands)

 

Beginning balance

 

$

4,176

 

 

$

2,370

 

 

$

4,096

 

 

$

2,370

 

Warranties assumed as part of the Merger

 

 

 

 

 

1,220

 

 

 

 

 

 

1,254

 

Settlements made

 

 

(651

)

 

 

(427

)

 

 

(1,081

)

 

 

(552

)

Provisions

 

 

2,439

 

 

 

871

 

 

 

2,949

 

 

 

962

 

Ending balance

 

$

5,964

 

 

$

4,034

 

 

$

5,964

 

 

$

4,034

 

 

Litigation and Asserted Claims

In a matter associated with Ramtron International Corporation (“Ramtron”), a wholly owned subsidiary of Cypress, bankruptcy proceedings are ongoing in Italy where the trustee for four bankrupt entities of Finmek S.pA. is seeking refunds of approximately $2.8 million in payments made by Finmek to Ramtron prior to Finmek’s bankruptcy in 2004. In November 2014, one of the courts presiding over these proceedings found that two payments should be refunded to Finmek, which currently total approximately $0.5 million, including interest and fees. The Company believes this ruling was made in error and has filed an appeal (Court of Appeal of Venice, Docket no. 2706/2015). The Company has prevailed in all other related proceedings, which the trustee may appeal (Court of Appeal of Venice, Docket Nos. 1387/2014 and 2487/2015; Tribunal of Padua Docket No. 5378/2009). Due to the current stage of the proceedings and the appellate process, the Company cannot reasonably estimate the loss or the range of possible loss, if any.

In 2013, a former employee filed a grievance against the Company with the U.S. Department of Labor (“DOL”) seeking back pay and reinstatement or forward pay. That matter was tried before an administrative law judge in July 2014. In December 2014, the administrative law judge issued a ruling in favor of the former employee for amounts totaling approximately $1.3 million. On March 30, 2016, the ruling was affirmed by the DOL Administrative Review Board (ARB).  The Company believes both rulings were erroneous and filed an appeal in the United States Court of Appeals for the Tenth Circuit on April 29, 2016 (Case No. 16-9523).  The respective positions of the parties and the appellate process prevent a reasonable determination of the outcome at this time. This former employee also filed a complaint for wrongful termination in state court in El Paso County, Colorado on March 4, 2015 (Case No. 2015-cv-030632). The state court litigation is stayed pending resolution of the DOL matter. The Company believes the state court action is meritless and will defend against the allegations.

24


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

After our announcement of the merger between the Company and Spansion Inc. in December 2014, two separate putative class action complaints (Walter Jeter v. Spansion Inc., et. al. (No. 114-cv-274635) and Shiva Y. Stein v. Spansion Inc., el. al. (No. 114-cv-274924)) were filed in Santa Clara County Superior Court in December 2014, alleging claims of breach of fiduciary duty against Spansion’s board of directors and naming Cypress as a defendant for aiding and abetting the alleged breach of fiduciary duty. While Cypress believes these lawsuits to be meritless, Spansion and Cypress entered into a memorandum of understanding with plaintiffs, the terms of which required additional disclosures by the Company and payment of nominal attorneys’ fees to the class counsel. Final resolution of these litigations will require court approval of a final settlement agreement.  Due to the current stage of the proceedings, the Company cannot reasonably estimate the loss or the range of possible loss, if any.

The Company is involved in various trademark opposition proceedings with Kingston Technology Corporation (“Kingston”) concerning Kingston’s “HYPERX” trademark and the Company’s “HYPERRAM” trademark, including Trademark Trial and Appeal Board Proceeding Nos. 91218100, 91222728, and 92061796.  The Company believes its defenses and counterclaims have merit and will continue to defend its intellectual property.  Due to the current stage of the proceedings, the Company cannot reasonably estimate the loss or the range of possible loss, if any.

On May 17, 2016, a patent infringement case was filed by North Star Innovations, Inc. (“North Star”) against the Company and UMC Group USA in the U.S. District Court for the District of Delaware (Case No. 16-cv-00368).  North Star alleges that the Company infringes three patents.  The matter is still in the very early stages and the Company will defend against the allegations accordingly.  Due to the current stage of the proceedings, the Company cannot reasonably estimate the loss or the range of possible loss, if any.

The Company is currently a party to various other legal proceedings, claims, disputes and litigation arising in the ordinary course of business. Based on its own investigations, the Company believes the ultimate outcome of the current legal proceedings, individually and in the aggregate, will not have a material adverse effect on its financial position, results of operation or cash flows. However, because of the nature and inherent uncertainties of the litigation, should the outcome of these actions be unfavorable, the Company's business, financial condition, results of operations or cash flows could be materially and adversely affected.

Indemnification Obligations

The Company is a party to a variety of agreements pursuant to which it may be obligated to indemnify other parties to such agreements with respect to certain matters. Typically, these obligations arise in the context of contracts that the Company has entered into, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants or terms and conditions related to such matters as the sale and/or delivery of its products, title to assets sold, certain intellectual property claims, defective products, specified environmental matters and certain income taxes. In these circumstances, payment by the Company is customarily conditioned on the other party making a claim pursuant to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party’s claims and vigorously defend itself and the third party against such claims. Further, the Company's obligations under these agreements may be limited in terms of time, amount or the scope of its responsibility and in some instances, the Company may have recourse against third parties for certain payments made under these agreements.

It is not possible to predict the maximum potential amount of future payments under these agreements due to the conditional nature of the Company's obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments the Company has made under these agreements have not had a material effect on the Company’s business, financial condition or results of operations. Management believes that if the Company were to incur a loss in any of these matters, such loss would not have a material effect on its business, financial condition, cash flows or results of operations, although there can be no assurance of this. As of July 3, 2016, the Company had no reason to believe a loss exceeding amounts already recognized had been incurred.

 

 

25


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

NOTE 11. FOREIGN CURRENCY DERIVATIVES

The Company enters into multiple foreign exchange forward contracts to hedge certain operational exposures resulting from fluctuations in Japanese yen and Euro exchange rates.  The Company does not enter into derivative securities for speculative purposes. The Company’s hedging policy is designed to mitigate the impact of foreign currency exchange rate fluctuations on its operating results. Some foreign currency forward contracts were considered to be economic hedges that were not designated as hedging instruments while others were designated as cash flow hedges. Whether designated or undesignated as cash flow hedges or not, these forward contracts protect the Company against the variability of forecasted foreign currency cash flows resulting from revenues, expenses and net asset or liability positions designated in currencies other than the U.S. dollar.  The maximum original duration of any contract allowable under the Company’s hedging policy is thirteen months.

Cash Flow Hedges

The Company enters into cash flow hedges to protect non-functional currency inventory purchases and certain other operational expenses, in addition to its on-going program of cash flow hedges to protect its non-functional currency revenues against variability in cash flows due to foreign currency fluctuations. The Company’s foreign currency forward contracts that were designated as cash flow hedges have maturities between three and nine months. All hedging relationships are formally documented, and the hedges are designed to offset changes to future cash flows on hedged transactions at the inception of the hedge. The Company recognizes derivative instruments from hedging activities as either assets or liabilities on the balance sheet and measures them at fair value on a monthly basis. The Company records changes in the intrinsic value of its cash flow hedges in accumulated other comprehensive income on the Condensed Consolidated Balance Sheets, until the forecasted transaction occurs. Interest charges or “forward points” on the forward contracts are excluded from the assessment of hedge effectiveness and are recorded in interest and other income (expense), net in the Condensed Consolidated Statements of Operations. When the forecasted transaction occurs, the Company reclassifies the related gain or loss on the cash flow hedge to revenue or costs, depending on the risk hedged.  In the event the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the Company will reclassify the gain or loss on the related cash flow hedge from accumulated other comprehensive income to interest and other income (expense), net in its Condensed Consolidated Statements of Operations at that time.

The Company evaluates hedge effectiveness at the inception of the hedge prospectively as well as retrospectively and records any ineffective portion of the hedge in interest and other income (expense), net in its Condensed Consolidated Statements of Operations.

At July 3, 2016, the Company had outstanding forward contracts to buy approximately ¥1,522 million for $13.5 million.

Non-designated hedges

Total notional amounts of net outstanding contracts were as summarized below:

 

Buy / Sell

 

July 3, 2016

 

 

January 3, 2016

 

 

 

(in millions)

 

US dollar / Japanese Yen

 

 

-

 

 

$19.4 / ¥2,333

 

US dollar / EUR

 

$19.3/€17.4

 

 

$7.3/€6.8

 

Japanese Yen / US dollar

 

¥701.7 / $7.4

 

 

 

-

 

 

The effect of derivative instruments on the Condensed Consolidated Statements of Operations for the three and six months ended July 3, 2016 was immaterial.

 

26


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

The gross fair values of derivative instruments on the Condensed Consolidated Balance Sheets as of July 3, 2016 and January 3, 2016 were as follows:

 

 

 

July 3, 2016

 

 

January 3, 2016

 

Balance Sheet location

 

Derivatives designated as hedging instruments

 

 

Derivatives not designated as hedging instruments

 

 

Derivatives designated as hedging instruments

 

 

Derivatives not designated as hedging instruments

 

 

 

(in thousands)

 

Other Current Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative Asset

 

$

11,312

 

 

$

5

 

 

$

966

 

 

$

17

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Current Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative Liability

 

$

9,813

 

 

$

545

 

 

$

1,283

 

 

$

99

 

 

 

NOTE 12. INCOME TAXES

The Company's income tax benefit was $5.2 million and income tax expense was $2.9 million for the three months ended July 3, 2016 and June 28, 2015, respectively.  The Company’s income tax benefit was $1.5 million for the six months ended July 3, 2016 and the Company’s income tax benefit was $1.1 million for the six months ended June 28, 2015.  The tax benefit for the six months ended July 3, 2016 was primarily attributable to a release of previously accrued taxes related to the lapsing of statutes of limitation, primarily offset by income taxes associated with the Company’s non-US operations.  The tax benefit for the six months ended June 28, 2015 was primarily a result of non-U.S. income taxes on income earned in foreign jurisdictions which was partially offset by the tax impact of accounting for certain acquired assets and liabilities as a result of the Merger resulting in $5.3 million  of the Company’s valuation allowance being released.  

Unrecognized Tax Benefits

As of July 3, 2016 and January 3, 2016 the amount of unrecognized tax benefits that, if recognized, would affect the Company's effective tax rate totaled $26.4 million and $28.4 million, respectively.

Management believes events that could occur in the next 12 months which could cause a material change in unrecognized tax benefits include, but are not limited to, the following:

 

·

completion of examinations by the U.S. or foreign taxing authorities; and

 

·

expiration of statute of limitations on the Company's tax returns.

The calculation of unrecognized tax benefits involves dealing with uncertainties in the application of complex global tax regulations. Management regularly assesses the Company’s tax positions in light of legislative, bilateral tax treaty, regulatory and judicial developments in the countries in which the Company does business. The Company believes it is reasonably possible that it may recognize up to approximately $4.1 million of its existing unrecognized tax benefits within the next twelve months as a result of the lapse of statutes of limitations and the resolution of agreements with domestic and various foreign tax authorities.

Classification of Interest and Penalties

The Company classifies interest and penalties as components of the income tax provision in the Condensed Consolidated Statements of Operations. As of July 3, 2016 and January 3, 2016, the amounts of accrued interest and penalties totaled $9.5 million and $12.0 million, respectively.

 

 

27


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

NOTE 13. NET LOSS PER SHARE

The following table sets forth the computation of basic and diluted net loss per share:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands, except per-share amounts)

 

Net loss attributable to Cypress

 

$

(519,274

)

 

$

(90,051

)

 

$

(623,296

)

 

$

(336,849

)

Weighted-average common shares

 

 

314,305

 

 

 

333,334

 

 

 

317,330

 

 

 

264,547

 

Weighted-average diluted shares

 

 

314,305

 

 

 

333,334

 

 

 

317,330

 

 

 

264,547

 

Net loss per share—basic

 

$

(1.65

)

 

$

(0.27

)

 

$

(1.96

)

 

$

(1.27

)

Net loss per share—diluted

 

$

(1.65

)

 

$

(0.27

)

 

$

(1.96

)

 

$

(1.27

)

 

For the three months ended July 3, 2016 and June 28, 2015, approximately 7.7 million and 16.6 million, weighted average potentially dilutive securities consisting of outstanding stock options, RSUs and PSUs and Convertible debt, respectively, were excluded in the computation of diluted net income per share because their effect would have been anti-dilutive. For the six months ended July 3, 2016 and June 28, 2015, approximately 8.9 million and 30.4 million, weighted average potentially dilutive securities consisting of outstanding stock options, unvested restricted RSUs and PSU’s and Convertible debt, respectively, were excluded in the computation of diluted net income (loss) per share because their effect would have been anti-dilutive.

 

 

NOTE 14. SEGMENT, GEOGRAPHICAL AND CUSTOMER INFORMATION

Segment Information

The Company designs, develops, manufactures and markets a broad range of high-performance solutions for embedded systems, from automotive, industrial and networking platforms to highly interactive consumer and mobile devices. In connection with Cypress’s merger with Spansion, the Company has aligned Spansion's two major product groups with Cypress's existing business segments: legacy Spansion flash memory products are reported in the Company's Memory Products Division and legacy Spansion microcontroller and analog products are reported in the Company's Programmable Systems Division.

 

Revenue

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

Programmable Systems Division

 

$

166,813

 

 

$

202,806

 

 

$

330,797

 

 

$

277,624

 

Memory Products Division

 

 

238,130

 

 

 

255,157

 

 

 

446,993

 

 

 

363,835

 

Data Communications Division

 

 

25,474

 

 

 

19,087

 

 

 

45,602

 

 

 

37,653

 

Emerging Technologies Division

 

 

19,710

 

 

 

7,728

 

 

 

45,699

 

 

 

14,803

 

Total revenue

 

$

450,127

 

 

$

484,778

 

 

$

869,091

 

 

$

693,915

 

 

28


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

Loss before Income Taxes

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

Programmable Systems Division

 

$

(5,478

)

 

$

12,999

 

 

$

(16,080

)

 

$

(6,975

)

Memory Products Division

 

 

53,370

 

 

 

49,838

 

 

 

90,199

 

 

 

(12,737

)

Data Communications Division

 

 

(7,238

)

 

 

(3,630

)

 

 

(15,697

)

 

 

(6,145

)

Emerging Technologies Division

 

 

2,341

 

 

 

(3,208

)

 

 

11,007

 

 

 

(5,998

)

Unallocated items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

(18,849

)

 

 

(27,667

)

 

 

(42,387

)

 

 

(46,464

)

Amortization of intangible assets

 

 

(32,605

)

 

 

(42,670

)

 

 

(67,792

)

 

 

(69,707

)

Restructuring costs, including CEO severance

 

 

(5,154

)

 

 

(10,039

)

 

 

(5,424

)

 

 

(85,754

)

Changes in value of deferred compensation plan

 

 

(254

)

 

 

54

 

 

 

(840

)

 

 

(1,187

)

Impact of purchase accounting and other

 

 

(19,937

)

 

 

(61,974

)

 

 

(51,180

)

 

 

(101,215

)

Impairment of acquisition-related intangible assets

 

 

 

 

 

 

 

 

(33,944

)

 

 

 

 

Goodwill impairment charge

 

 

(488,504

)

 

 

 

 

 

(488,504

)

 

 

 

Loss before income taxes

 

$

(522,308

)

 

$

(86,297

)

 

$

(620,642

)

 

$

(336,182

)

 

The Company does not allocate goodwill and intangible assets impairment charges, impact of purchase accounting, IPR&D, severance and retention costs, acquisition-related costs, stock-based compensation, interest income and other, and interest expense to its segments. In addition, the Company does not allocate assets to its segments. The Company excludes these items consistent with the manner in which it internally evaluates its results of operations.

Geographical Information

The following table presents revenues by geographical locations 1

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

United States

 

$

41,037

 

 

$

44,698

 

 

$

89,214

 

 

$

75,362

 

Europe

 

 

68,297

 

 

 

59,623

 

 

 

129,873

 

 

 

92,293

 

Asia:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater China 2

 

 

190,806

 

 

 

158,028

 

 

 

334,389

 

 

 

227,317

 

Japan

 

 

93,387

 

 

 

160,711

 

 

 

206,582

 

 

 

194,870

 

Rest of the World

 

 

56,600

 

 

 

61,718

 

 

 

109,033

 

 

 

104,073

 

Total revenue

 

$

450,127

 

 

$

484,778

 

 

$

869,091

 

 

$

693,915

 

 

 

1.

Prior period numbers have been revised to conform to current period presentation.  During the three months ended July 3, 2016, the Company started presenting this information based on location of customers to whom the sale of products was made.

 

2.

Greater China includes China, Taiwan and Hong Kong.

 

29


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

Property, plant and equipment, net, by geographic locations were as follows:

 

 

 

As of

 

 

 

July 3, 2016

 

 

January 3, 2016

 

 

 

(In thousands)

 

United States

 

$

249,208

 

 

$

269,304

 

Philippines

 

 

88,160

 

 

 

90,356

 

Thailand

 

 

30,920

 

 

 

34,233

 

Japan

 

 

15,428

 

 

 

9,537

 

Other

 

 

18,653

 

 

 

21,573

 

Total property, plant and equipment, net

 

$

402,369

 

 

$

425,003

 

 

The Company tracks its assets by physical location. Although management reviews asset information on a corporate level and allocates depreciation expense by segment, the Company’s chief operating decision maker does not review asset information on a segment basis.

Customer Information

Outstanding accounts receivable from three of the Company's distributors accounted for 27.5%, 9.3% and 8.0% of its consolidated accounts receivable as of July 3, 2016. Outstanding accounts receivable from three of the Company's distributors, accounted for 42%, 11% and 9% of its consolidated accounts receivable as of January 3, 2016.

Revenue generated through one of the Company's distributors accounted for 24.0% of its consolidated revenue for the three months ended July 3, 2016.  Revenue generated through one of the Company’s distributor accounted for 24.0% of its consolidated revenue for the six months ended July 3, 2016. No end customer accounted for 10% or more of the Company's revenues for the three and six months ended July 3, 2016.

Revenue generated through one of the Company's distributors accounted for 29% of its consolidated revenue for the three months ended June 28, 2015.  Revenue generated through two of the Company’s distributors accounted for 23% and 10% of its consolidated revenue for the six months ended June 28, 2015.  One end customer accounted for 10% or more of the Company’s revenue for the three and six months ended June 28, 2015.

 

 

NOTE 15. SUBSEQUENT EVENTS

 

Joinder and Amendment Agreement

 

On July 5, 2016 the Company entered into a Joinder and Amendment Agreement with the guarantors party thereto, the initial incremental term loan lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent . The Joinder Agreement supplements the Company’s existing Amended and Restated Credit and Guaranty Agreement, dated as of March 12, 2015, by and among the Company, the guarantors, the lenders, the Agent, and Morgan Stanley Bank, N.A., as issuing bank and others.

 

The Joinder and Amendment Agreement provides for the incurrence by the Company of an incremental term loan in an aggregate principal amount of $450.0 million. The incurrence of the Incremental Term Loan is permitted as an incremental loan under the Credit Agreement and is subject to the terms of the Credit Agreement and to additional terms set forth in the Joinder and Amendment Agreement. The Incremental Term Loan will initially bear interest at (i) with respect to any portion of the Incremental Term Loan that is a LIBOR rate loan 5.50% or (ii) with respect to any portion of the Incremental Term Loan that is a base rate loan, 4.50%.  Following the Company’s delivery of a compliance certificate and financial statements for the Company’s third fiscal quarter of 2016, the Incremental Term Loan shall bear interest, at the Company’s option, at (i) an adjusted LIBOR rate plus an applicable margin of either 5.25% or 5.50%, or (ii) an adjusted base plus an applicable margin of either 4.25% or 4.50%, with the applicable margin in each case determined based on the Company’s total net leverage ratio for the trailing twelve month period ended as of the last day of the Company’s most recently ended fiscal quarter. The Company paid an upfront fee to the initial incremental lenders in an amount equal to 1.5% of the aggregate principal amount of the Incremental Term Loan funded. The Company is required to pay a prepayment premium of 1% of the principal amount prepaid if it prepays the Incremental Term Loan in certain circumstances prior to the date that is twelve months after the Closing Date. The Incremental Term Loan was fully funded on the Closing Date and matures on July 5, 2021.

30


CYPRESS SEMICONDUCTOR CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(Unaudited)

 

 

The proceeds of the Incremental Term Loan were used to finance a portion of purchase price for the Company’s acquisition of certain assets used in the operation of Broadcom Corporation’s Internet of Things business, and to pay fees and expenses incurred in connection with the acquisition.

 

Broadcom Asset Purchase Agreement

 

On July 5, 2016, the Company completed its acquisition of certain assets primarily related to the Internet of Things business of Broadcom Corporation pursuant to an Asset Purchase Agreement with Broadcom, dated April 28, 2016. In connection with the closing of the transaction the Company paid Broadcom $550 million in cash.  The revenue from sales of Wi-Fi Bluetooth and Zigbee radio products acquired as part of this acquisition, will be reported in the Company’s Data Communications Division.  The Company is currently evaluating the purchase price allocation for this transaction.

 

Deca Investment

 

On July 29, 2016, Deca Technologies Inc. (“Deca”), a partially owned subsidiary of the Company, completed a $111.4 million equity investment by certain investors pursuant to a Class I Preferred Share Purchase.   In connection with the closing of the transaction, Deca repurchased $20.6 million of Class G preferred shares from the Company.  Following the Closing, the Company’s ownership in Deca was reduced to 52.2% based on its shares outstanding on July 29, 2016.

 

 

 

31


 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The Management’s Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties, which are discussed in the “Forward-Looking Statements” section under Part I of this Quarterly Report on Form 10-Q.

EXECUTIVE SUMMARY

Overview

Cypress Semiconductor Corporation (“Cypress” or “the Company”) manufactures and sells in advanced embedded system solutions for automotive, industrial, home automation and appliances, consumer electronics and medical products. Cypress’s programmable systems-on-chip, general-purpose microcontrollers, analog ICs, wireless and USB-based connectivity solutions and memories help engineers design differentiated products and help with speed to market. Cypress is committed to providing customers with quality support and engineering resources.

Merger with Spansion

On March 12, 2015, we completed the merger (“Merger”) with Spansion Inc. ("Spansion") pursuant to the Agreement and Plan of Merger and Reorganization, dated as of December 1, 2014 (the "Merger Agreement"), for a total consideration of approximately $2.8 billion. In accordance with the terms of the Merger Agreement, Spansion shareholders received 2.457 Cypress shares for each Spansion share they owned. The Merger has been accounted for under the acquisition method of accounting in accordance with Financial Accounting Standards Board Accounting Standard Topic 805, Business Combinations, with Cypress treated as the accounting acquirer. To date, the Company has incurred $96.5 million of merger and integration costs in addition to restructuring and other items associated with the Merger and integration. The post-Merger company is expected to realize more than $180 million in cost synergies on an annualized basis within three years, and create a leading global provider of microcontrollers and specialized memories needed in today's embedded systems.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations includes the financial results of legacy Spansion beginning March 12, 2015. The comparability of our operating results for the six months ended July 3, 2016 to the same period in fiscal 2015 is significantly impacted by our merger with Spansion. In our discussion and analysis of comparative periods, we have quantified the contribution of additional revenue or expense resulting from this transaction wherever such amounts were material and identifiable. While identified amounts may provide indications of general trends, the analysis cannot completely address the effects attributable to integration efforts.

Divestiture of TrueTouch® Business

In connection with the sale of the TrueTouch® Mobile touchscreen business to Parade Technologies (“Parade”) on August 1, 2015, we entered into a Manufacturing Service Agreement (MSA) in which we agreed to sell finished wafers and devices to Parade during the one-year period following the close of the transaction.  The terms of the MSA provide that we would sell finished products to Parade at agreed-upon prices that were considered below fair market value, indicating that there was an embedded fair value that would be realized by Parade through those terms.  Accordingly, we have allocated approximately $19.9 million from the $98.6 million proceeds to the fair value of the MSA based on the forecasted wafer sales to Parade for the subsequent one-year period.  That amount was deferred on our consolidated balance sheet initially and is being amortized to revenue as we sell products to Parade.  During the three and six months ended July 3, 2016, we recognized approximately $3.7 million and $8.4 million of revenue from amortization of the deferred revenue.

Business Segments

We evaluate our reportable business segments in accordance with the accounting guidance. In connection with our Merger, we have aligned Spansion's two major product groups for embedded applications with our existing product divisions: Spansion's flash memory with our Memory Products Division and Spansion's microcontroller and analog products with our Programmable Systems Division.

32


 

We operate in the following four reportable business segments:

 

Business Segments

 

Description

 

 

 

PSD: Programmable Systems Division

 

PSD focuses on high-performance, programmable solutions. The portfolio includes Traveo™ automotive microcontrollers, PSoC® programmable system-on-chip products, ARM® Cortex®-M4, -M3, -M0+ microcontrollers and R4 CPUs, analog PMIC Power Management ICs and automotive LED drivers, CapSense® capacitive-sensing controllers, TrueTouch® touchscreen solutions, fingerprint reader products, and PSoC Bluetooth Low Energy solutions for the IoT. Effective March 12, 2015, PSD added Spansion’s microcontroller and analog products

 

 

 

MPD: Memory Products Division

 

MPD focuses on high-performance serial and parallel NOR Flash memories, NAND Flash memories, static random access memory (SRAM), and high-reliability F-RAM™ ferroelectric memory and nonvolatile SRAM (nvSRAM) devices. Effective March 12, 2015, MPD added Spansion’s Flash memory products.

 

 

 

DCD: Data Communications Division

 

DCD focuses on USB controllers, including solutions for the USB Type-C and USB Power Delivery standards; Wi-Fi, Bluetooth, Bluetooth Low Energy and ZigBee solutions; PRoC™ programmable radio-on-chip solutions; WirelessUSB™ solutions; and module solutions such as trackpads and Bluetooth Low Energy modules. Effective July 5, 2016, DCD added Broadcom’s wireless IoT products.

 

 

 

ETD: Emerging Technologies Division

 

Also known as our “startup” division, ETD includes subsidiaries AgigA Tech Inc. and Deca Technologies Inc., as well as our foundry business and other development-stage activities.

 

Our primary focus is profitable growth in our key markets. With the addition of the legacy Spansion business and or acquisition of the Broadcom Corporations’ wireless IoT business (the “Broadcom IoT Business”) which closed July 5, 2016, we plan to capitalize on our expanded product portfolio and market positions in advanced embedded systems solutions to extend our penetration of global markets such as automotive, industrial, communications, consumer, computation, data communications and military. Our revenue model is based on the following product and market strategies: (a) growing revenue from our high-performance, programmable solutions and derivatives including PSoC programmable system-on-chip products and microcontrollers in the automotive and industrial markets, (b) increasing our DCD revenue through the integration of Wi-Fi, Bluetooth and ZigBee radios from the Broadcom  IoT Business acquisition and through the introduction of new products such as USB Type-C solutions, SuperSpeed USB 3.0 peripheral controllers and Bluetooth® Low Energy solutions that leverage Cypress’s PRoC™ programmable radio-on-chip technology for the IoT and other applications, (c) increasing market share in our memory products by leveraging our market position and expanding our portfolio with new and complementary products, and (d) revenue growth from ETD, which includes our internal startup companies. For profitability, our focus is to finish integrating the acquired Spansion business successfully and fully realize the anticipated product cost and operational cost synergies. Our integration effort includes the re-focusing of portions of the legacy Spansion business to higher-margin opportunities, particularly in the Flash memory business. We monitor our operating expenses closely to improve our operating leverage.

In order to achieve our goals on revenue growth and profitability, Cypress will continue to pursue the following strategies:

 

·

Cross-sell products from Cypress’s expanded product portfolio in the wake of the Spansion Merger and Broadcom IoT Business acquisition. We will continue to pursue product and business synergies to reduce costs and grow our revenue.

 

·

Focus on large and growing markets, particularly automotive, industrial and Internet of Things. We will continue to pursue business opportunities in large and growing markets leveraging our unique mix of PSoC and microcontrollers, memories, Wi-Fi, Bluetooth, Bluetooth Low Energy and ZigBee wireless solutions, USB Type-C controllers, capacitive touch-sensing solutions, analog power management ICs and other products.

 

·

Successfully complete the integration of our business with Spansion. We are committed to integrating the businesses of Cypress and Spansion successfully to finish realizing the anticipated cost synergies and improve profitability.

 

·

Drive profitability through tight management of operating expenses. Cypress maintains a corporate wide focus on margin and operating expenses. We are committed to maintaining our operating expense management without compromising our new product development and investments in our Emerging Technologies Division.

33


 

 

·

Collaborate with customers to build system-level solutions. We work closely with our customers from initial product design through manufacturing and delivery to optimize their design efforts, help them achieve product differentiation, improve their time-to-market and help them to develop whole product solutions. 

 

·

Drive programmable technologies, extend our leadership in programmable products and drive PSoC proliferation. We will continue to define, design and develop new programmable products and solutions that offer our customers increased flexibility and efficiency, higher performance, and higher levels of integration with a focus on analog functionality. We will continue to drive PSoC and microcontroller adoption in our key market segments.

 

·

Leverage flexible manufacturing. Our manufacturing strategy combines capacity from leading foundries with output from our internal manufacturing facilities. This enables us to adjust to rapid swings in customer demand while reducing the burden of fixed costs.

 

·

Pursue complementary strategic relationships. We will continue to assess opportunities to develop strategic relationships through acquisitions, investments, licensing and joint development projects. We also will continue to make investments in current ventures as well as new ventures.

As we continue to implement our strategies, there are many internal and external factors that could impact our ability to meet any or all of our objectives. Some of these factors are discussed under Part I Item 1A in our Annual Report on Form 10-K for the year ended January 3, 2016 as well as in Item 1A in this Quarterly Report on Form 10-Q.

Results of Operations

Revenues

Our total revenues decreased by $34.7 million or 7.1% to $450.1million for the three-month period ended July 3, 2016 compared to the same period in the prior year primarily due to decrease in revenue from TrueTouch® mobile business as a result of divestiture of the business on August 1, 2015 . The overall average selling price of our products for the three months ended July 3, 2016 was $1.20 and it did not change compared with the same period in the prior year.

Our total revenues increased by $175.2 million or 25.2% to $869.1 million for the six-month period ended July 3, 2016 compared to the same period in the prior year. For the six months ended July 3, 2016, approximately $209.1 million of the increase was attributable to revenue contributions from the acquired Spansion business which is included in the PSD and MPD divisions, which was offset by decrease in revenue from TrueTouch® mobile business as a result of divestiture of the business on August 1, 2015.  The overall average selling price of our products for the six months ended July 3, 2016 was $1.19 which did not change compared with the same period in the prior year. Excluding Spansion products, our average selling price (“ASP”) for the six months ended July 3, 2016 was $1.13, which increased by $0.02 compared with the same period in the prior year.

Consistent with our accounting policies and generally accepted accounting principles, we have historically recognized a significant portion of revenue through distributors at the time the distributor resold the product to its end customer (also referred to as the sell-through basis of revenue recognition) given the difficulty in estimating the ultimate price of these product shipments and amount of potential returns. We continually reassess our ability to reliably estimate the ultimate price of these products and, over the past several years, we have made investments in our systems and processes around our distribution channel to improve the quality of the information we receive from our distributors. Given these ongoing investments, and based on the financial framework we use for estimating potential price adjustments,  in the fourth quarter of 2014 the Company began recognizing revenue on certain product families and with certain distributors (less its estimate of future price adjustments and returns) upon shipment to the distributors (also referred to as the sell-in basis of revenue recognition).  

During the three months ended July 3, 2016, we recognized an incremental $24.2 million of revenue, on additional product families for which revenue was previously recognized on a sell-through basis as we determined that we could reasonably estimate returns and pricing concessions at the time of shipment to distributors. This change resulted in a decrease to the net loss of $6.8 million or $0.02 per basic and diluted share for the three months ended July 3, 2016. During the three month ended June 28, 2015, there were no new product families or distributors for which we recognized revenue on a sell-in basis.  During the six months ended July 3, 2016, we recognized approximately $40.6 million of incremental revenue from this change in revenue recognition, which resulted in a decrease to our net loss of approximately $14.2 million for the six months ended July 3, 2016, or approximately $0.05 per basic and diluted shares. During the six months ended June 28, 2015, we recognized approximately $22.7 million of incremental revenue from this change, which resulted in a decrease to our net loss of approximately $13.7 million for the six months ended June 28, 2015, or approximately $0.05 per basic and diluted shares.  

34


 

During the three months ended July 3, 2016, we recognized approximately $306.5 million or 92.8% of distribution revenue on a sell-in basis. During the three months ended June 28, 2015, we recognized approximately $220.7 million or 62.5% of distribution revenue on a sell-in basis.  During the six months ended July 3, 2016, we recognized approximately $540.0 million or 86.9% of distribution revenue on a sell-in basis, respectively. During the six months ended June 28, 2015, we recognized approximately $329.1 million or 51.1% of distribution revenue on a sell-in basis, respectively.

The following table summarizes our consolidated revenues by segments:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

Programmable Systems Division

 

$

166,813

 

 

$

202,806

 

 

$

330,797

 

 

$

277,624

 

Memory Products Division

 

 

238,130

 

 

 

255,157

 

 

 

446,993

 

 

 

363,835

 

Data Communications Division

 

 

25,474

 

 

 

19,087

 

 

 

45,602

 

 

 

37,653

 

Emerging Technologies Division

 

 

19,710

 

 

 

7,728

 

 

 

45,699

 

 

 

14,803

 

Total revenue

 

$

450,127

 

 

$

484,778

 

 

$

869,091

 

 

$

693,915

 

 

Programmable Systems Division:

Revenues from the PSD decreased by $36.0 million and increased by $53.2 million in the three and six months ended July 3, 2016 or decreased by 17.7% and increased by19.2%, respectively, compared to the same prior-year period.   The decrease in the three months ended July 3, 2016 as compared to the same prior-year period was driven by decrease in sales in the mobile market segment as a result of the sale of TrueTouch® mobile business on August 1, 2015.  The increase for the six month period ended July 3, 2016 as compared to the same prior-year period was due to $87.7 million of revenue contributions from Spansion products.  Excluding the impact of Spansion revenues, PSD decreased $34.5 million for the six months ended July 3, 2016 or $29.0%, compared to same prior-year period primarily due to a $36.2 million decrease in revenue from TrueTouch® mobile business as a result of divestiture of the business on August 1, 2015.

The overall average selling price of our products for PSD for the three and six months ended July 3, 2016 was $1.32 and $1.24 which increased by $0.25 and $0.23 compared with the same prior-year period.

Memory Products Division:

Revenues from the MPD decreased by approximately $17.1 million and increased by $83.2 million or decreased by 6.7% and increased by 22.9% in the three and six months ended July 3, 2016, compared to the same prior-year period. The decrease in the three months ended July 3, 2016 as compared to the same prior-year period was primary driven by decrease in the consumer market segment. The increase for the six months period ended July 3, 2016 as compared to the same prior-year period was due to $117.4 million of revenue contribution from the Spansion flash memory business.  Excluding the impact of Spansion revenues, MPD decreased by $34.2 million in the six months ended July 3, 2016, or 20.5% compared to the same prior-year period, primarily driven by decrease in sales in the industrial market segment.

The overall ASP’s of our products for MPD for the three and six months ended July 3, 2016 were $1.27 and $1.28, respectively,  which decreased  by $0.11 and $0.18 compared with the same prior-year period.

Data Communications Division:

Revenues from the DCD increased by approximately $6.4 million and $8.0 million or 33.5% and 21.1% in the three and six months ended July 3, 2016, respectively, compared to the same prior-year period due to increasing revenue in our super speed USB, trackpad and Type C products.

The overall ASP’s of our products for DCD, for the three and six months ended July 3, 2016 were $0.59 and $0.63, respectively, which decreased  by $0.22 and $0.18 compared with the same prior-year period.

35


 

Emerging Technologies Division:

Revenues from the ETD increased by approximately  $12.0 million and $30.9 million or 155.0%  and 208.7% in the three and six months ended July 3, 2016, respectively, compared to the same prior-year periods primarily due to the overall increase in customer demand at all of our ETD companies.  The increase were also attributable to increases in our Foundry revenues as we began selling products to Parade Technologies in August 2015 under the Manufacturing Services Agreement, which was signed in connection with our disposition of the TrueTouch® Mobile business.

Cost of Revenues

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

June 28, 2015

 

 

 

(In thousands)

 

Cost of revenues

 

$

291,349

 

 

$

346,705

 

 

$

584,528

 

$

597,535

 

As a percentage of revenue

 

 

65

%

 

 

72

%

 

 

67

%

 

86.1

%

 

Our cost of revenue ratio is significantly impacted by the mix of products we sell, which is often difficult to forecast with accuracy. Therefore, if we achieve significant revenue growth in our lower margin (i.e. revenue less cost of revenue) product lines, or if we are unable to earn as much revenue as we expect from higher margin product lines, our gross margin may be negatively impacted. Our cost of revenue ratio improved from 71.5% during the three months ended June 28, 2015 to 64.7% in the three months ended July 3, 2016. The primary driver of the improvement in the cost of revenue ratio was lower amortization of fair value adjustments, net of reserves, relating to acquired Spansion inventory.  Write downs of inventories were $7.6 million and $13.9 million for the three months ended July 3, 2016 and June 28, 2015, respectively.  Sale of inventory that was previously written-off or written-down aggregated $14.1 million and $6.7 million for the three months ended July 3, 2016 and June 28, 2015, respectively, which favorably impacted our cost of revenues ratio by 3.1% for the three months ended July 3, 2016 and by 1.4% for the three months ended June 28, 2015.  This impact was offset by lower fab utilization, which was 53% in the second quarter of fiscal 2016, lower compared to same prior-year period.

Our cost of revenue ratio improved from 86.1% during the six months ended June 28, 2015 to 67.2% in the six months ended July 3, 2016. The primary driver of the improvement in the cost of revenue ratio was lower write downs of carrying value of inventory during the six months ended July 3, 2016 as compared to the same period in previous fiscal year.  Included in the cost of revenues in the six months ended June 28, 2015 was $133.0 million write-down of carrying value of inventory assumed as a part of the Spansion Merger, as well as a write-down of $19.1 million of certain other inventories. In comparison, write-down of inventories in the six months ended July 3, 2016 was $15.6 million.  Sale of inventory that was previously written-off or written-down aggregated $21.2 million and $8.2 million for the six months ended July 3, 2016 and June 28, 2015, respectively, which favorably impacted our cost of revenues ratio by 2.4% and 1.2% for the six months ended July 3, 2016 and June 28, 2015, respectively. This impact was offset by lower fab utilization which was 53% in the second quarter of fiscal 2016, lower as compared to prior -year.

Research and Development (“R&D”) Expenses

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

 

 

 

 

 

 

 

 

R&D expenses

 

$

70,171

 

 

$

81,227

 

 

$

144,138

 

 

$

131,749

 

As a percentage of revenues

 

 

15.6

%

 

 

16.8

%

 

 

16.6

%

 

 

19.0

%

 

R&D expenditures decreased by $11.1 million in the three months ended July 3, 2016 compared to the same prior-year period. The decrease was primarily attributable to $6.1 million of reduced labor costs primarily due to headcount reduction, $1.6 million decrease in stock based compensation expense and a decrease of $0.8 million in costs for outside services.

 

R&D expenditures increased by $12.4 million in the six months ended July 3, 2016 compared to the same prior-year period. The increase was primarily attributable to $6.9 million of higher labor costs due to additional headcount, $2.1 million of building, repairs and other overhead expenses and $1.5 million higher professional services and legal fees.

36


 

Selling, General and Administrative (“SG&A”) Expenses

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

 

 

 

 

 

 

 

 

SG&A expenses

 

$

81,836

 

 

$

91,840

 

 

$

156,336

 

 

$

162,300

 

As a percentage of revenues

 

 

18.2

%

 

 

18.9

%

 

 

18.0

%

 

 

23.4

%

 

SG&A expenses decreased by $10.0 million in the three months ended July 3, 2016 compared to the same prior-year period. The decrease was primarily attributable to $7.6 million decrease in stock based compensation expense and a decrease of $1.3 million in professional fees related to the ongoing Spansion merger integration activities.

SG&A expenses decreased by $6.0 in the six months ended July 3, 2016 compared to the same prior-year period. The decrease was mainly due to a decrease of $16.2 million in acquisition and integration related expenses and a $5.5 million decrease in stock based compensation expense primarily offset by $4.5 million for CEO severance costs, $3.3 million increase in labor costs, $4.0 million increase in building, supplies, repairs, other overhead expenses and professional services costs and $1.7 million higher marketing costs.

Amortization of acquisition-related intangible assets

Amortization expense decreased by $3.3 million in the three months ended July 3, 2016 compared to the same period in the prior year mainly due to certain intangibles that were fully amortized during fiscal 2016.  The decrease was partially offset by amortization related to capitalized in-process research and development projects which started amortization fiscal 2015 as well as three months ended July 3, 2016.

Amortization expense increased by $24.5 million in the six months ended July 3, 2016 compared to the same period in the prior year.  The increase was mainly due to the amortization on the intangibles acquired in connection with the Spansion Merger as well as capitalization of some in-process research and development projects.

Impairment of acquisition-related intangible assets

In the six months ended July 3, 2016, we recognized approximately $33.9 million of impairment charge related to two IPR&D projects that were cancelled due to certain change in our long-term product portfolio strategy during fiscal 2016.  

Goodwill impairment charge

Our results for the three months ended July 3, 2016 included a non-cash goodwill impairment charge of $488.5 million related to our PSD reporting unit. The goodwill impairment charge resulted from a combination of factors including, (a) decreases in our forecasted operating results when compared with the expectations of the PSD reporting unit at the time of the Merger, primarily in consumer markets as the Company has subsequently increased its focus on the automotive and industrial end markets, (b) evaluation of business priorities due to recent changes in management, and (c) certain market conditions necessitated a quantitative impairment analysis for the carrying value of the Goodwill related to PSD.

Restructuring

In March 2015, we began the implementation of planned cost reduction and restructuring activities in connection with the Merger. The restructuring charges of $0.7 million and $0.9 million recorded for the three and six months ended July 3, 2016, respectively, primarily consisted of severance costs, lease termination costs and impairment of property, plant and equipment. The lease termination restructuring costs recorded in the six months ended June 28, 2015 included $17.9 million related to the buildings Spansion had leased prior to the Merger, which we decided not to occupy in the post-Merger period.  The initial term of these leases commenced on January 1, 2015 and will expire on December 31, 2026.

37


 

The following table summarizes the restructuring charges recorded in our Condensed Consolidated Statements of Operations for the periods presented pursuant to the Spansion Integration-Related Restructuring Plan:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

 

(In thousands)

 

Personnel costs

 

$

369

 

 

$

11,120

 

 

$

615

 

 

$

55,326

 

Lease termination costs and other related charges

 

 

285

 

 

 

(845

)

 

 

309

 

 

 

17,897

 

Impairment of property, plant and equipment

 

 

 

 

 

(236

)

 

 

 

 

 

12,531

 

Total restructuring and other charges

 

$

654

 

 

$

10,039

 

 

$

924

 

 

$

85,754

 

 

We anticipate that the remaining restructuring liability balance will be paid out in cash through the end of 2016 for employee terminations and over the remaining lease term through 2026 for the excess lease obligation.

As of July 3, 2016, we have realized approximately $165.5 million of synergy savings on an annualized basis from the restructuring actions taken. Upon completion of all of our actions, we anticipate our annualized synergy savings in fiscal year 2016 to be approximately $180 million. When complete, we estimate approximately 40% of the savings will impact cost of goods sold and the remaining 60% will impact operating expenses. There can be no assurance that we will achieve these anticipated savings.

Income Taxes

Our income tax benefit was $5.2 million and income tax expense was $2.9 million for the three months ended July 3, 2016 and June 28, 2015, respectively.  Our income tax benefit was $1.5 million and $1.1 million for the six months ended July 3, 2016 and June 28, 2015, respectively. The tax benefit for the six months ended July 3, 2016 was primarily attributable to a release of previously accrued taxes related to the lapsing of statutes of limitation, primarily offset by income taxes associated with our non-US operations. The tax benefit for the six months ended June 28, 2015 was primarily a result of non-U.S. income taxes on income earned in foreign jurisdictions, which were more than offset by the tax impact of accounting for certain acquired assets and liabilities as a result of the Merger resulting in $5.3 million of the Company’s valuation allowance being released.  

LIQUIDITY AND CAPITAL RESOURCES

The following table summarizes information regarding our cash and cash equivalents and short-term investments and working capital:

 

 

 

As of

 

 

 

July 3, 2016

 

 

January 3, 2016

 

 

 

(In thousands)

 

Cash and cash equivalents

 

$

188,333

 

 

$

226,690

 

Short-term investments

 

 

970

 

 

 

871

 

Total cash, cash equivalents and short-term investments

 

$

189,303

 

 

$

227,561

 

Total current assets

 

$

863,005

 

 

$

850,772

 

Total current liabilities

 

 

533,227

 

 

 

528,396

 

Working capital

 

$

329,778

 

 

$

322,376

 

 

Key Components of Cash Flows

 

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands)

 

Net cash provided by (used in) operating activities

 

$

22,503

 

 

$

(53,016

)

Net cash provided by (used in) investing activities

 

$

(34,183

)

 

$

(135,311

)

Net cash provided by (used in) financing activities

 

$

(26,677

)

 

$

208,731

 

 

38


 

Operating Activities

Net cash provided by operating activities of $22.5 million during the six months ended July 3, 2016 was primarily due to a net loss of $623.8 million which included net non-cash expense items of $704.0 million.  The non-cash expense items primarily consisted of depreciation and amortization of $122.7 million, a goodwill impairment charge of $488.5 million, a $33.9 million impairment charge for acquisition-related intangibles and stock based compensation expense of $42.2 million. This was partially offset by net cash used from increase in operating assets and liabilities for the six months ended July 3, 2016 of $57.7 million. The net cash used from changes in operating assets and liabilities during the six months ended July 3, 2016 was primarily due to the following:

 

·

an increase in accounts receivable of $32.4 million due to timing of shipments during the six months ended July 3, 2016.  The days sales outstanding for the six months ended July 3, 2016 and January 3, 2016 were 68 days and 61 days respectively;

 

·

a decrease in inventories of $22.6 million as part of our lean inventory initiative pursuant to which we are running our manufacturing facilities below demand levels to burn through excess inventory from the Spansion Merger;

 

·

an increase in other current and long-term assets of $36.6 million, primarily due to timing of payments for certain licenses;

 

·

an increase in accounts payable, accrued and other liabilities of $43.3 million due to timing of payments;

 

·

a decrease in deferred income of $54.5 million due to the transition of additional product families to the sell-in basis of revenue recognition.

Investing Activities

During the six months ended July 3, 2016, we used approximately $34.2 million of cash in our investing activities primarily due to $25.8 million of cash used for property and equipment expenditures relating to purchases of certain tooling, laboratory and manufacturing facility equipment and $14.4 million cash paid for certain investments, of which $12.0 million related to our investment in a company that designs, develops and manufactures advanced battery storage products for mobile consumer devices.

Financing Activities

During the six months ended July 3, 2016, we used approximately $26.7 million of cash in our financing activities primarily related to the repurchase of stock in the amount of $175.7 million, net repayments of $82.0 million on the revolving credit facility, $70.8 million dividend payments, purchase of capped call for the 4.50% Senior Exchangeable Notes and repayments of capital leases and Term Loan A of $9.1 million.  Such payments were primarily offset by our net borrowings on the 4.50% Senior Convertible Notes of $279.4 million and proceeds of $40.1 million from employee equity awards.

Liquidity and Contractual Obligations

Contractual Obligations

The following table summarizes our contractual obligations as of July 3, 2016:

 

 

 

Total

 

 

2016

 

 

2017 and 2018

 

 

2019 and 2020

 

 

After 2020

 

 

 

(In thousands)

 

Purchase obligations (1)

 

$

320,728

 

 

$

66,185

 

 

$

150,942

 

 

$

103,601

 

 

$

 

Equipment loan

 

 

1,511

 

 

 

1,511

 

 

 

 

 

 

 

 

 

 

Operating lease commitments (2)

 

 

77,047

 

 

 

9,406

 

 

 

28,720

 

 

 

14,154

 

 

 

24,767

 

Capital lease commitments

 

 

5,675

 

 

 

5,675

 

 

 

 

 

 

 

 

 

 

2.00% Senior Exchangeable Notes

 

 

149,990

 

 

 

 

 

 

 

 

 

149,990

 

 

 

 

4.50% Senior Exchangeable Notes

 

 

287,500

 

 

 

 

 

 

 

 

 

 

 

 

287,500

 

Term Loan A

 

 

97,500

 

 

 

2,500

 

 

 

15,000

 

 

 

80,000

 

 

 

 

Interest payment on debt

 

 

141,446

 

 

 

8,079

 

 

 

63,656

 

 

 

50,252

 

 

 

19,459

 

Senior Secured Revolving Credit Facility

 

 

367,000

 

 

 

 

 

 

 

 

 

367,000

 

 

 

 

Total contractual obligations

 

$

1,448,397

 

 

$

93,356

 

 

$

258,318

 

 

$

764,997

 

 

$

331,726

 

39


 

 

(1)

Purchase obligations primarily include non-cancelable purchase orders for materials, services, manufacturing equipment, building improvements and supplies in the ordinary course of business. Purchase obligations are defined as enforceable agreements that are legally binding on us and that specify all significant terms, including quantity, price and timing.

(2)

Operating leases includes payments relating to Spansion's lease for office space in San Jose for a new headquarters entered on May 22, 2014, which is no longer required. The lease is for a period of 12 years, with two options to extend for periods of five years each after the initial lease term. The term of the lease commenced on January 1, 2015 and expires on December 31, 2026.

As of July 3, 2016, our unrecognized tax benefits were $26.4 million, which were classified as long-term liabilities. We believe it is possible that we may recognize up to approximately $4.1 million of our existing unrecognized tax benefits within the next twelve months as a result of the lapse of statutes of limitations and the resolution of agreements with domestic and various foreign tax authorities.

Equity Investment Commitments

We have committed to purchase additional preferred stock from a company that operates in the area of advanced battery storage. During the three and six months ended July 3, 2016, we purchased an additional $7.0 million and $12.0 million, respectively,  of preferred stock which was recorded as part of our investments in non-marketable securities. Subject to the attainment of certain milestones, we may purchase additional preferred stock of this company.

Capital Resources and Financial Condition

Our long-term strategy is to maintain a minimum amount of cash and cash equivalents for operational purposes and to invest the remaining amount of our cash in interest-bearing and highly liquid cash equivalents and debt securities, payments of regularly scheduled cash dividends, the repayment of our short-term debt, and the purchase of our stock through our stock buyback program. As of July 3, 2016, in addition to $188.3 million in cash and cash equivalents, we had $1.0 million invested in short-term investments for a total cash, cash equivalents and short-term investment balance of $189.3 million.  As of July 3, 2016, approximately 15% of our cash, cash equivalents and available-for-sale investments were held in offshore funds. While these amounts are primarily invested in U.S. dollars, a portion is held in foreign currencies. All offshore balances are exposed to local political, banking, currency control and other risks. In addition, these amounts, if repatriated, may be subject to tax and other transfer restrictions.  

On July 5, 2016 we entered into a Joinder and Amendment Agreement with the guarantor’s party thereto for an incremental term loan in an aggregate principal amount of $450.0 million. The incurrence of the Incremental Term Loan is permitted as an incremental loan under the Credit Agreement and is subject to the terms of the Credit Agreement and to additional terms set forth in the Joinder and Amendment Agreement. The proceeds of the Incremental Term Loan were used to finance a portion of purchase price for the Company’s acquisition of certain assets used in the operation of Broadcom Corporation’s Internet of Things business, and to pay fees and expenses incurred in connection with the acquisition. The contractual obligations table above does not include the commitments related to the said incremental term loan.

We believe that the liquidity provided by existing cash, cash equivalents and available-for-sale investments and our borrowing arrangements will provide sufficient capital to meet our requirements for at least the next twelve months. However, should prevailing economic conditions and/or financial, business and other factors beyond our control adversely affect the estimates of our future cash requirements; we could be required to fund our cash requirements by alternative financing. There can be no assurance that additional financing, if needed, would be available on terms acceptable to us or at all. In addition, we may choose at any time to raise additional capital or debt to strengthen our financial position, facilitate growth, enter into strategic initiatives including the acquisition of other companies and provide us with additional flexibility to take advantage of other business opportunities that arise.

Recent Accounting Pronouncements

See “Recent Accounting Pronouncements” in Note 1 of Notes to Consolidated Financial Statements under Item 8 in our Annual Report on Form 10-K for the year ended January 3, 2016 and Note 1 of Notes to Condensed Consolidated Financial Statements under Item 1 in our Quarterly Report on Form 10-Q for the period ended April 3, 2016.

40


 

Non-GAAP Financial Measures

To supplement its consolidated financial results presented in accordance with GAAP, Cypress uses the following non-GAAP financial measures which are adjusted from the most directly comparable GAAP financial measures:

 

·

Revenue

 

·

Research and development expenses

 

·

Selling, general and administrative expenses

 

·

Operating income (loss)

 

·

Net income (loss)

 

·

Diluted net income (loss) per share

Management believes that these non-GAAP financial measures reflect an additional and useful way of viewing aspects of the Company’s operations that, when viewed in conjunction with the Company’s GAAP results, provide a more comprehensive understanding of the various factors and trends affecting the Company’s business and operations. Management uses these non-GAAP measures for strategic and business decision-making, internal budgeting, forecasting and resource allocation processes. In addition, these non-GAAP financial measures facilitate management’s internal comparisons to the Company’s historical operating results and comparisons to competitors’ operating results.  

Each of the non-GAAP financial measures excludes one or more of the following items:

Acquisition-related charges: Acquisition-related charges are not factored into management’s evaluation of potential acquisitions or the Company’s performance after completion of acquisitions, because they are not related to the Company’s core operating performance. However, a limitation of non-GAAP measures that exclude acquisition-related charges is that these charges may represent payments that reduce the cash available to the Company for other purposes. Acquisition-related expenses primarily include:

 

 

 

Amortization of purchased intangibles, including purchased technology, patents, customer relationships, trademarks, backlog and non-compete agreements;

 

 

 

Amortization of step-up in value of inventory recorded as part of purchase price accounting; and

 

 

 

One-time charges associated with completing an acquisition including items such as contract termination costs, severance and other acquisition-related restructuring costs; costs incurred in connection with integration activities, and legal and accounting costs.

Share-based compensation expense: Share-based compensation expense relates primarily to employee stock options, restricted stock units, performance stock units and the employee stock purchase plan. Share-based compensation expense is a non-cash expense that is affected by changes in market factors including the price of the Company’s common shares, which are not within the control of management. In addition, the valuation of share-based compensation is subjective, and the expense recognized by the Company may be significantly different than the expense recognized by other companies for similar equity awards, which makes it difficult to assess the Company’s results compared to its competitors. Accordingly, management excludes this item from its internal operating forecasts and models. However, a limitation of non-GAAP measures that exclude share-based compensation expense is that they do not reflect the full costs of compensating employees.

Other adjustments: These items are excluded from non-GAAP financial measures because they are not related to the core operating activities and ongoing operating performance of the Company. Excluding these items, which can vary significantly from quarter to quarter, allows management to better compare the Company’s period-over-period performance. However, limitations of non-GAAP measures that exclude these items include that these adjustments are often subjective and may not be comparable to similarly-titled non-GAAP financial measures used by other companies. Other adjustments primarily include:

 

 

 

Revenue from an intellectual property license,

 

 

 

Changes in value of deferred compensation plan assets and liabilities,

 

 

 

Investment-related gains or losses, including equity method investments,

 

 

 

Restructuring and related costs,

 

 

 

Debt issuance costs, including imputed interest related to the equity component of convertible debt,

 

41


 

 

 

Asset impairments,

 

 

 

Tax effects of non-GAAP adjustments,

 

 

 

Certain other expenses and benefits, and

 

 

 

Diluted weighted average shares non-GAAP adjustment – for purposes of calculating non-GAAP diluted earnings per share, the GAAP diluted weighted average shares outstanding is adjusted to exclude the benefits of share-based compensation expense attributable to future services not yet recognized in the financial statements that are treated as proceeds assumed to be used to repurchase shares under the GAAP treasury stock method.

Please refer to the tables below for GAAP to Non-GAAP reconciliation items related to the three and six months ended July 3, 2016 and June 28, 2015.

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

(In thousands, except per share amounts)

 

 

(In thousands, except per share amounts)

 

Non-GAAP revenue

 

$

456,377

 

 

$

491,028

 

 

$

881,591

 

 

$

700,164

 

Non-GAAP cost of revenue

 

$

283,836

 

 

$

289,733

 

 

$

552,208

 

 

$

501,529

 

Non-GAAP research and development expenses

 

$

64,582

 

 

$

73,144

 

 

$

130,812

 

 

$

117,106

 

Non-GAAP selling, general and administrative expenses

 

$

58,670

 

 

$

67,206

 

 

$

117,351

 

 

$

107,484

 

Non-GAAP operating income (loss)

 

$

49,289

 

 

$

60,947

 

 

$

81,220

 

 

$

(25,955

)

Non-GAAP net income attributable to Cypress

 

$

40,196

 

 

$

52,870

 

 

$

63,180

 

 

$

(35,036

)

Non-GAAP net income per share attributable to

   Cypress—diluted

 

$

0.12

 

 

$

0.15

 

 

$

0.19

 

 

$

(0.13

)

CYPRESS SEMICONDUCTOR CORPORATION

RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES (a)

(In thousands, except per-share data)

(Unaudited)

 

Table A: Revenue

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

 

 

GAAP revenue

 

$

450,127

 

 

$

484,778

 

 

$

869,091

 

 

$

693,915

 

Add: Revenue from Intellectual Property License

 

 

6,250

 

 

 

6,250

 

 

 

12,500

 

 

 

6,250

 

Non-GAAP revenue

 

$

456,377

 

 

$

491,028

 

 

$

881,591

 

 

$

700,165

 

 

Table B: GAAP to Non-GAAP reconciling items (Three months ended July 3, 2016)

 

 

 

 

Cost of revenues

 

 

Research and development

 

 

SG&A

 

 

Amortization of Intangible assets

 

 

Goodwill impairment charge

 

 

Interest and other expense, net

 

 

Income tax benefit (provision)

 

GAAP

 

 

$

291,349

 

 

$

70,171

 

 

$

82,490

 

 

$

32,605

 

 

$

488,504

 

 

$

9,884

 

 

$

5,221

 

[1] Stock based compensation, including costs related to modification of equity awards

 

 

 

4,278

 

 

 

5,329

 

 

 

9,242

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

[2] Changes in value of deferred compensation plan

 

 

 

86

 

 

 

242

 

 

 

530

 

 

 

-

 

 

 

-

 

 

 

(604

)

 

 

-

 

[3] Merger, integration and related costs

 

 

 

3,149

 

 

 

19

 

 

 

8,514

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

[4] Losses from equity method investments

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,568

 

 

 

-

 

[5] Imputed interest on convertible debt and other

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,919

 

 

 

-

 

[6] Amortization of Intangible assets

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

32,605

 

 

 

-

 

 

 

-

 

 

 

-

 

[7] Restructuring costs, including CEO severance

 

 

 

-

 

 

 

-

 

 

 

5,153

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

[8] Goodwill impairment charge

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

488,504

 

 

 

-

 

 

 

-

 

[9] Tax impact of Non-GAAP adjustments

 

 

 

-

 

 

 

-

 

 

 

380

 

 

 

-

 

 

 

-

 

 

 

(292

)

 

 

(8,402

)

Non-GAAP

 

 

$

283,836

 

 

$

64,581

 

 

$

58,671

 

 

$

-

 

 

$

-

 

 

$

6,293

 

 

$

(3,181

)

42


 

 

Table C: GAAP to Non-GAAP reconciling items (Three months ended June 28, 2015)

 

 

 

Cost of revenues

 

 

Research and development

 

 

SG&A

 

 

Amortization of Intangible assets

 

 

Interest and other expense, net

 

 

Income tax benefit (provision)

 

GAAP

 

$

346,705

 

 

$

81,227

 

 

$

101,879

 

 

$

35,928

 

 

$

6,795

 

 

$

(2,935

)

[1] Stock based compensation

 

 

3,802

 

 

 

7,007

 

 

 

16,859

 

 

 

-

 

 

 

-

 

 

 

-

 

[2] Changes in value of deferred compensation plan

 

 

46

 

 

 

153

 

 

 

276

 

 

 

-

 

 

 

(528

)

 

 

-

 

[3] Merger, integration and related costs

 

 

52,799

 

 

 

827

 

 

 

7,465

 

 

 

-

 

 

 

-

 

 

 

-

 

[4] Losses from equity method investments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,382

 

 

 

-

 

[5] Imputed interest on convertible debt and other

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

993

 

 

 

-

 

[6] Amortization of  Intangible assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

35,928

 

 

 

-

 

 

 

-

 

[7] Tax impact of Non-GAAP adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(834

)

[8] Restructuring costs

 

 

-

 

 

 

-

 

 

 

10,073

 

 

 

-

 

 

 

-

 

 

 

-

 

[8] Other charges

 

 

325

 

 

 

96

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non - GAAP

 

$

289,733

 

 

$

73,144

 

 

$

67,206

 

 

$

-

 

 

$

4,948

 

 

$

(3,769

)

 

Table D: GAAP to Non-GAAP reconciling items (Six months ended July 3, 2016)

 

 

 

Cost of revenues

 

 

Research and development

 

 

SG&A

 

 

Amortization of Intangible assets

 

 

Impairment of acquisition-related intangible assets

 

 

Goodwill impairment charge

 

 

Interest and other expense, net

 

 

Income tax benefit (provision)

 

GAAP

 

$

584,528

 

 

$

144,138

 

 

$

157,260

 

 

$

67,792

 

 

$

33,944

 

 

 

488,504

 

 

$

18,213

 

 

$

1,479

 

[1] Stock based compensation, including costs

   related to modification of equity awards

 

 

9,925

 

 

 

12,260

 

 

 

20,202

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

[2] Changes in value of deferred compensation

   plan

 

 

133

 

 

 

372

 

 

 

813

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(478

)

 

 

-

 

[3] Merger, integration and related costs

 

 

22,262

 

 

 

694

 

 

 

13,090

 

 

 

-

 

 

 

33,944

 

 

 

-

 

 

 

-

 

 

 

-

 

[4] Losses from equity method investments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,646

 

 

 

-

 

[5] Imputed interest on convertible debt and other

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,254

 

 

 

-

 

[6] Amortization of  Intangible assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

67,792

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

[7] Goodwill impairment charge

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

488,504

 

 

 

 

 

 

 

 

 

[8] Tax impact of Non-GAAP adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8,241

)

[9] Restructuring costs, including CEO severance

 

 

-

 

 

 

-

 

 

 

5,804

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Non - GAAP

 

$

552,208

 

 

$

130,812

 

 

$

117,351

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

11,791

 

 

$

(6,762

)

43


 

 

Table E: GAAP to Non-GAAP reconciling items (Six months ended June 28, 2015)

 

 

 

Cost of revenues

 

 

Research and development

 

 

SG&A

 

 

Amortization of Intangible assets

 

 

Restructuring costs

 

 

Interest and other expense, net

 

 

Income tax benefit (provision)

 

GAAP

 

$

597,535

 

 

$

131,749

 

 

$

162,300

 

 

$

43,274

 

 

$

85,754

 

 

$

12,503

 

 

$

1,068

 

[1] Stock based compensation

 

 

8,021

 

 

 

12,757

 

 

 

25,686

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

[2] Changes in value of deferred compensation plan

 

 

235

 

 

 

770

 

 

 

1,386

 

 

 

-

 

 

 

-

 

 

 

(1,201

)

 

 

-

 

[3] Merger, integration and related costs

 

 

87,305

 

 

 

957

 

 

 

27,054

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

[4] Losses from equity method investments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

3,018

 

 

 

-

 

[5] Imputed interest on convertible debt and other

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,787

 

 

 

-

 

[6] Amortization of  Intangible assets

 

 

-

 

 

 

-

 

 

 

-

 

 

 

43,274

 

 

 

-

 

 

 

-

 

 

 

-

 

[7] Tax impact of Non-GAAP adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,532

)

[8] Restructuring costs

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

85,754

 

 

 

-

 

 

 

-

 

[9] Other charges

 

 

445

 

 

 

158

 

 

 

690

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Non - GAAP

 

$

501,529

 

 

$

117,107

 

 

$

107,484

 

 

$

-

 

 

$

-

 

 

$

5,899

 

 

$

(4,464

)

 

Table F: Operating income (loss)

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP operating loss

 

$

(514,992

)

 

$

(80,961

)

 

$

(607,075

)

 

$

(326,697

)

Add: Net impact of Non-GAAP adjustments (see tables A,B,C, D

   and E)

 

 

564,281

 

 

 

141,907

 

 

 

688,295

 

 

 

300,742

 

Non-GAAP operating income (loss)

 

$

49,289

 

 

$

60,946

 

 

$

81,220

 

 

$

(25,955

)

 

Table G: Net income (loss)

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Net loss

 

$

(519,274

)

 

$

(90,051

)

 

$

(623,296

)

 

$

(336,849

)

Add: Net impact of Non-GAAP adjustments (see tables A,B,C, D

   and E)

 

 

559,470

 

 

 

142,921

 

 

 

686,476

 

 

 

301,813

 

Non-GAAP Net income (loss)

 

$

40,196

 

 

$

52,870

 

 

$

63,180

 

 

$

(35,036

)

 

Table H: Net income (loss) Per Share

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Net loss per share - Diluted

 

$

(1.65

)

 

$

(0.27

)

 

$

(1.96

)

 

$

(1.27

)

Excluded Items per share impact of Non-GAAP adjustments

 

 

1.77

 

 

 

0.42

 

 

 

2.15

 

 

 

1.14

 

Non-GAAP earnings per share-Diluted

 

$

0.12

 

 

$

0.15

 

 

$

0.19

 

 

$

(0.13

)

 

Table I: Weighted-average shares

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2016

 

 

June 28, 2015

 

 

July 3, 2016

 

 

June 28, 2015

 

Weighted-average common shares outstanding basic - GAAP

 

 

314,305

 

 

 

333,334

 

 

 

317,330

 

 

 

264,547

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options, unvested restricted stock and other

 

 

12,858

 

 

 

13,764

 

 

 

12,114

 

 

 

 

 

Impact of convertible bond

 

 

12,577

 

 

 

15,668

 

 

 

12,577

 

 

 

 

Weighted-average common shares outstanding diluted Non-GAAP

 

 

339,740

 

 

 

362,766

 

 

 

342,021

 

 

 

264,547

 

44


 

 

(a)

Refer to the accompanying “Non-GAAP financial measures” for a detailed discussion of management’s use of non-GAAP financial measures. 

CRITICAL POLICIES AND ESTIMATES

The discussion and analysis of our financial condition and results of operations are based upon our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q and the data used to prepare them. Our Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States and we are required to make estimates, judgments and assumptions in the course of such preparation. Note 1 of Notes to Condensed Consolidated Financial Statements under Part I Item 1 describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. On an ongoing basis, we re-evaluate our judgments and estimates including those related to revenue recognition, allowances for doubtful accounts receivable, inventory valuation, valuation of long-lived assets, goodwill and financial instruments, stock-based compensation, and settlement costs, and income taxes. We base our estimates and judgments on historical experience, knowledge of current conditions and our beliefs of what could occur in the future considering available information. Actual results may differ from these estimates under different assumptions or conditions.

As discussed in Part II, Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended January 3, 2016, we consider the following accounting policies to be the most critical in understanding the judgments that are involved in preparing our consolidated financial statements:

 

·

Revenue Recognition

 

·

Business Combinations

 

·

Allowance for Doubtful Accounts Receivables

 

·

Valuation of Inventories

 

·

Valuation of Long-Lived Assets

 

·

Valuation of Goodwill

 

·

Fair Value of Financial Instruments

 

·

Cash Flow Hedges

 

·

Stock-Based Compensation

 

·

Employee Benefits Plan

 

·

Accounting for Income Taxes

There have been no changes to our critical accounting policies since the filing of our last Annual Report on Form 10-K.

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risks

Our investment portfolio consists of a variety of financial instruments that expose us to interest rate risk, including, but not limited to, money market funds, certificate of deposit and corporate securities. These investments are generally classified as available-for-sale and, consequently, are recorded on our balance sheets at fair market value with their related unrealized gain or loss reflected as a component of accumulated other comprehensive income in stockholders’ equity. Due to the relatively short-term nature of our investment portfolio, we do not believe that an immediate 10% increase in interest rates would have a material effect on the fair market value of our portfolio. Since we believe we have the ability to liquidate this portfolio, we do not expect our operating results or cash flows to be materially affected to any significant degree by a sudden change in market interest rates on our investment portfolio.

Foreign Currency Exchange Risk

We operate and sell products in various global markets and purchase capital equipment using foreign currencies but predominantly the U.S. dollar. Pursuant to our Merger, we are exposed to certain risks associated with changes in foreign currency exchange rates in Japanese yen and other foreign currencies and are exposed to foreign currency exchange rate fluctuations.

45


 

For example,

 

·

sales of our products to Fujitsu are denominated in U.S. dollars, Japanese yen and Euros;

 

·

some of our manufacturing costs are denominated in Japanese yen, and other foreign currencies such as the Thai baht and Malaysian ringgit;

 

·

some of our operating expenses are denominated in Japanese yen and

 

·

some fixed asset purchases and sales are denominated in other foreign currencies.

Consequently, movements in exchange rates could cause our revenues and our expenses to fluctuate, affecting our profitability and cash flows. We use foreign currency forward contracts to reduce our foreign exchange exposure on our foreign currency denominated assets and liabilities. We also hedge a percentage of our forecasted revenue denominated in Japanese yen with foreign currency forward contracts. The objective of these contracts is to mitigate impact of foreign currency exchange rate movements to our operating results on a short term basis. We do not use these contracts for speculative or trading purposes.

We recognize derivative instruments from hedging activities as either assets or liabilities on the balance sheet and measure them at fair value. Gains and losses resulting from changes in fair value are accounted for depending on the use of the derivative and whether it is designated and qualifies for hedge accounting. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. We record changes in the intrinsic value of these cash flow hedges in accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets, until the forecasted transaction occurs. When the forecasted transaction occurs, we reclassify the related gain or loss on the cash flow hedge to the appropriate revenue or expense line of the Condensed Consolidated Statements of Operations. In the event the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we will reclassify the gain or loss on the related cash flow hedge from accumulated other comprehensive loss to interest and other income (expense), net in our Condensed Consolidated Statements of Operations at that time.

We evaluate hedge effectiveness at the inception of the hedge prospectively as well as retrospectively and record any ineffective portion of the hedging instruments in interest and other income (expense), net in our Condensed Consolidated Statements of Operations.

We analyzed our foreign currency exposure, including our hedging strategies, to identify assets and liabilities denominated in other currencies. For those assets and liabilities, we evaluated the effects of a 10% shift in exchange rates between those currencies and the U.S. dollar. We have determined that there would be an immaterial effect on our results of operations from such a shift. Please see Note 11 of the Notes to Condensed Consolidated Financial Statements for details on the contracts.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including the Office of the President and Chief Executive Officer, which currently performs the duties of the President and Chief Executive Officer, and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Based on their evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q and subject to the foregoing, the Office of the President and Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at a reasonable assurance level.

46


 

Changes in Internal Control over Financial Reporting

During the six months ended July 3, 2016, the Company expanded the scope of its internal controls over financial reporting to include the former operations of Spansion and its subsidiaries.  There were no other changes in our internal control over financial reporting that occurred during the three months period ended July 3, 2016 that have materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

47


 

PART II-OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The information required by this item is included in Note 10 of Notes to Condensed Consolidated Financial Statements under Item 1, Part 1 of this Quarterly Report on Form 10-Q and is incorporated herein by reference.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this report, including the following risk factors, you should carefully consider the risks and uncertainties discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended January 3, 2016, which could materially affect our business, financial condition or future results.  Unless they change, risk factors in the 10-K are not repeated here, but are incorporated by reference from the 10-K.  The risks described in our Annual Report on Form 10-K are not the only risks facing our Company.  Additional risks and uncertainties not currently known to us or that we currently deem to be not material also may materially and adversely affect our business, financial condition and/or operating results.

The trading price of our common stock has been and will likely continue to be volatile due to various factors, some of which are beyond our control, and each of which could adversely affect our stockholders’ value.

The trading price of our common stock has been and will likely continue to be volatile due to various factors, some of which are beyond our control, including, but not limited to:

 

·

Revenue fluctuations due to unexpected shifts in customer orders;

 

·

Announcements about our earnings or the earnings of our competitors that are not in line with analyst expectations;

 

·

Our ability to achieve the planned synergies in the 2015 merger with Spansion;

 

·

The impact on our business and financial results of our July 2016 acquisition of the Internet of Things (“IoT”) business of Broadcom Corporation (“Broadcom”);

 

·

Credit conditions and our ability to refinance our existing debt at commercially reasonable terms, which may limit the Company’s working capital;

 

·

Quarterly variations in our results of operations or those of our competitors, including but not limited to fluctuations due to significant non-cash charges such as the $488.5 million goodwill impairment charge we recorded in the second quarter of 2016;

 

·

Announcements by us or our competitors of acquisitions, new products, significant contracts, design wins, commercial relationships or capital commitments;

 

·

The perceptions of general market conditions in the semiconductor industry and global market conditions;

 

·

Our ability to develop and market new and enhanced products on a timely basis;

 

·

Any major change in our board or senior management;

 

·

Changes in governmental regulations or in the status of our regulatory compliance that impact our business;

 

·

Recommendations by securities analysts or changes in earnings estimates concerning us or our customers or competitors;

 

·

The volume of short sales, hedging and other derivative transactions on shares of our common stock;

 

·

Economic conditions and growth expectations in the markets we serve;

 

·

Changes in our policy regarding dividends or our ability to declare a dividend; and

 

·

Our ability to execute our lean inventory initiative to reduce excess inventory, which could lead to a disruption in the supply of our products and adversely affect our business.

Further, the stock market in general, and the market for technology companies in particular, have experienced extreme price and volume fluctuations. These broad market and industry factors may seriously harm the market price of our common stock, regardless of our actual operating performance. In the past, following periods of volatility in the overall market and the market price of a company’s securities, securities class action litigation has often been instituted against these companies. This litigation, if instituted against us, could result in substantial costs and a diversion of our management’s attention and resources. Finally, our executive officers, who may hold a substantial number of shares of our common stock, may from time to time pledge all or a portion of their holdings as collateral

48


 

or include such holdings in margin accounts. If our stock price were to drop suddenly, such margin accounts could be called and the shares in such accounts may be automatically sold by a third party in the open market, even during a trading blackout period under our Insider Trading Policy.

Our search for a permanent President and Chief Executive Officer may cause uncertainty regarding the future of our business, impact employee hiring and retention, increase the volatility in our stock price, and adversely impact our revenue, operating results, and financial condition.

On April 28, 2016, Dr. T.J. Rodgers resigned as our President and Chief Executive Officer after leading the Company for over 30 years. In connection with Dr. Rodgers’ resignation, the Board formed an Office of the President and Chief Executive Officer (“OCEO”), consisting of Thad Trent, our Executive Vice President, Finance and Administration, and Chief Financial Officer, Hassane El-Khoury, Executive Vice President of our Programmable Systems Division, Dana Nazarian, Executive Vice President of our Memory Products Division and Joseph Rauschmayer, our Executive Vice President of World Wide Manufacturing, which reports directly to the Board and performs the duties of the President and Chief Executive Officer until such time as a successor for Dr. Rodgers is duly appointed. In addition, our Board formed a CEO transition committee, which is overseeing the OCEO and conducting the search for a President and Chief Executive Officer both internally and externally to succeed Dr. Rodgers. Upon appointment of a new President and Chief Executive Officer, Dr. Rodgers will offer his resignation as a member of the Board, which resignation shall be accepted or declined by the Board in its sole discretion. The Board has begun a search for a permanent replacement.  The Board’s search for a President and Chief Executive Officer, and any related speculation and uncertainty regarding our future business strategy and direction in connection with the search and the appointment of a permanent President and Chief Executive Officer, may cause or result in:

 

·

disruption of our business or distraction of our employees and management;

 

·

difficulty recruiting, hiring, motivating and retaining talented and skilled personnel, including a permanent President and Chief Executive Officer;

 

·

increased stock price volatility; and

 

·

difficulty in establishing, maintaining or negotiating business or strategic relationships or transactions

If we are unable to mitigate these or other potential risks related to the uncertainty caused by the Board’s search for a President and Chief Executive Officer, it may disrupt our business or adversely impact our revenue, operating results, and financial condition.  Further, there can be no assurance that we will be able to attract a qualified, permanent President and Chief Executive Officer who has the desired qualifications on acceptable terms, or at all.  Our inability to attract a qualified, permanent President and Chief Executive Officer could have a material adverse effect on our business and results of operations.

In the second quarter of 2016, we incurred a material impairment charge with respect to our goodwill, and we may in the future incur additional impairments in the value of our goodwill, intangibles and property, plant and equipment.

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. We test goodwill for impairment annually, and more frequently when events occur or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. In the second quarter of 2016, we conducted impairment testing on the goodwill in our Programmable Systems Division reporting unit, which we acquired in the Spansion merger, and recorded an impairment charge of $488.5 million. In addition, our other long-lived assets which include intangibles and property, plant and equipment are evaluated for impairments whenever events or changes in circumstances indicate the carrying value may not be recoverable. Either of these situations may occur for various reasons, including changes in actual or expected income or cash. We continue to evaluate current conditions to assess whether any impairment exists. Additional impairments could occur in the future if any of the following occur: market or interest rate environments deteriorate, significant adverse changes in business climate, unanticipated competition, loss of key customers, changes in technology, expected future cash flows of our reporting units decline, or reporting unit carrying values change materially compared with changes in respective fair values.

We face significant risks in connection with our acquisition of the IoT business of Broadcom that could impact our future growth and profitability.

On July 5, 2016, we completed our acquisition of the IoT business of Broadcom. See Note 15 of the Notes to the Condensed Consolidated Financial Statements. The success of the transaction will depend on a number of factors, including but not limited to our ability to successfully integrate the assets of the IoT business (including employees) into our Data Communications Division operations; our ability to achieve the anticipated strategic benefits of the acquisition; and our ability to keep transaction costs within an

49


 

anticipated range. The integration may take longer than anticipated and/or be more costly than anticipated. The addition of Broadcom’s IoT assets may not improve our ability to address the IoT market as much or as quickly as we anticipate. We have incurred significant costs associated with transaction fees, professional services and other costs related to the acquisition and we will continue to incur additional costs in connection with the integration of the business. If these costs exceed our expectations, it could have a material adverse impact on our operating results. Furthermore, we incurred substantial indebtedness to pay for the acquisition.  See the risk factor entitled “We utilize debt financing and such indebtedness could adversely affect our business, financial condition, results of operations and earnings per share. We may be unable to meet our payment obligations.”

We utilize debt financing and such indebtedness could adversely affect our business, financial condition, results of operations and earnings per share.  We may be unable to meet our payment obligations.

We routinely incur indebtedness to finance our operations and from time to time we have significant amounts of outstanding indebtedness and substantial debt service requirements. Our amended and restated senior secured credit facility with a group of lenders led by Morgan Stanley Senior Funding, Inc. (the “Credit Agreement”), provides for a $540 million revolving credit facility and a $100 million term loan. The credit facility contains customary affirmative, negative and financial covenants, including a maximum total leverage ratio and a minimum fixed charge coverage ratio. Our ability to meet our payment and other obligations and covenants under our indebtedness depends on our ability to generate significant cash flow. This, to some extent, is subject to general economic, financial, competitive, legislative and regulatory factors as well as other factors that are beyond our control. There is no assurance that our business will generate cash flow from operations, or that future borrowings will be available to us under our existing or any amended credit facilities or otherwise, in an amount sufficient to enable us to meet payment obligations under indebtedness we may under take from time to time. If we are not able to generate sufficient cash flow to service our debt obligations or meet required debt covenants, we may need to refinance or restructure our debt, sell assets, reduce or delay capital investments, or seek to raise additional capital. There is no assurance that we will be able to implement any of these alternatives on commercially reasonable terms, if at all. If we are unable to implement one or more of these alternatives, we may not be able to meet our payment obligations under any indebtedness we owe.

As of July 3, 2016, our outstanding debt included 367.0 million related to our Senior Secured Revolving Credit Facility, $150 million of 2.00% Senior Exchange Notes assumed from Spansion, $94.6 million Term Loan A, net of costs, $287.5 million of 4.50% Exchangeable Senior Notes due 2022, $5.7 million of capital leases and $1.5 million of equipment loans. See Note 8 for more information on our Senior Secured Revolving Credit Facility, 2.00% Senior Exchangeable Notes assumed from Spansion, our Term Loan A, the 4.50% Senior Exchangeable Notes and our capital leases.  See Note 15 for a description of our $450 million incremental term loan under our Credit Agreement, which closed on July 5, 2016.

We may dispose of certain businesses, product lines or assets, which could adversely affect our results of operations.

From time to time, we may divest certain businesses, product lines or assets, both acquired or otherwise, that are no longer strategically important, or we may exit minority investments, which could materially affect our cash flows and results of operations. If we decide to divest a business, product line or assets, we may encounter difficulty in finding or completing divestiture opportunities or alternative exit strategies on acceptable terms or in a timely manner. These circumstances could delay the achievement of our strategic objectives or cause us to incur additional expenses with respect to the business, product line or assets that we want to dispose of, or we may dispose of the business, product line or assets at a price or on terms that are less favorable than we had anticipated. Even following a divestiture, we may be contractually obligated with respect to certain continuing obligations to customers, vendors, landlords or other third parties. We may also have continuing obligations for pre-existing liabilities related to the assets or businesses. Such obligations may have a material adverse impact on our results of operations and financial condition. Any such dispositions could also result in disruption to other parts of our business, potential loss of employees or customers, incurring potential loss of revenue, negatively impacting margins, exposure to unanticipated liabilities or result in ongoing obligations and liabilities to us following any such divestiture. We may also incur significant costs associated with exit or disposal activities, related impairment charges, or both.

50


 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchase of Equity Securities

On October 20, 2015, we entered into a new $450 million stock buyback program.  Refer Note 9 for further details.  

The table below sets forth the information with respect to repurchases of common stock made in the second quarter of fiscal 2016 under the $450 million stock buyback program.

 

 

 

Total number

of shares

purchased

 

 

Average price

paid per share

 

 

Total shares

purchased as

part of the

publicly

announced

programs

 

 

Total dollar

value of shares

that may yet be

purchased

under this

program (In

thousands)

 

Remaining balance available for purchases at the beginning of the

   period

 

 

 

 

 

 

 

 

 

 

 

 

 

$

210,968

 

Withholding of common shares for tax obligations on vested

   restricted shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

April 2016

 

 

61

 

 

$

8.49

 

 

 

61

 

 

$

1

 

May 2016

 

 

1,870

 

 

$

9.44

 

 

 

1,870

 

 

$

18

 

June 2016

 

 

1,929

 

 

$

10.07

 

 

 

1,929

 

 

$

19

 

Total repurchases during Q2 2016

 

 

3,860

 

 

$

9.74

 

 

 

3,860

 

 

$

210,930

 

 

Issuer Sale of Senior Exchangeable Notes

On June 23, 2016, the Company issued $287.5 million of Senior Convertible Notes due 2022 (the “Notes”) in a private placement to qualified institutional buyers under Rule 144A of the Securities Act of 1933, as amended. See Note 8 of the Notes to Condensed Consolidated Financial Statements for further details.

 

51


 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

52


 

ITEM 6. EXHIBITS

 

 

 

 

 

Incorporated by Reference

Exhibit

 

Description

 

Form

 

Filing Date

 

File No.

 

Filed

Number

Herewith

 

 

 

 

 

 

 

 

 

 

 

3.1

 

Amended and Restated Bylaws of Cypress Semiconductor Corporation.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

4.1

 

Form of Capped Call Transaction.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

4.2

 

Indenture, dated June 23, 2016, by and between Cypress Semiconductor Corporation and U.S. Bank National Association.

 

8-K

 

6/23/2016

 

001-10079

 

 

 

 

 

 

 

 

 

 

 

 

 

10.1+

 

Form of Change of Control Severance Agreement.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

10.2

 

Purchase Agreement by and among Merrill Lynch, Pierce, Fenner & Smith Incorporated and Cypress Semiconductor Corporation dated as of June 20, 2016.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

10.3+

 

Employment Agreement and Release between Cypress Semiconductor Corporation and T.J. Rodgers dated June 3, 2016.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

10.4+

 

Severance Policy dated May 26, 2016.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

31.1

 

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

31.2

 

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

32.1++

 

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

32.2++

 

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

101.INS

 

XBRL Instance Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document.

 

 

 

 

 

 

 

 

 

+

Identifies a management contract or compensatory plan or arrangement.

 

++

Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities   Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

 

 

53


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

CYPRESS SEMICONDUCTOR CORPORATION

 

 

 

 

 

Date:    August 9, 2016

 

By:

 

/s/  THAD TRENT   

 

 

 

 

Thad Trent

 

 

 

 

Executive Vice President, Finance and Administration

and Chief Financial Officer

54


 

EXHIBIT INDEX

 

 

 

 

 

Incorporated by Reference

Exhibit

 

Description

 

Form

 

Filing Date

 

File No.

 

Filed

Number

Herewith

 

 

 

 

 

 

 

 

 

 

 

3.1

 

Amended and Restated Bylaws of Cypress Semiconductor Corporation.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

4.1

 

Form of Capped call Transaction.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

4.2

 

Indenture, dated June 23, 2016, by and between Cypress Semiconductor Corporation and U.S. Bank National Association.

 

8-K

 

6/23/2016

 

001-10079

 

 

 

 

 

 

 

 

 

 

 

 

 

10.1+

 

Form of Change of Control Severance Agreement.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

10.2

 

Purchase Agreement by and among Merrill Lynch, Pierce, Fenner & Smith Incorporated and Cypress Semiconductor Corporation dated as of June 20, 2016.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

10.3+

 

Employment Agreement and Release between Cypress Semiconductor Corporation and T.J. Rodgers dated June 3, 2016.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

10.4+

 

Severance Policy dated May 26, 2016.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

31.1

 

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

31.2

 

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

32.1++

 

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

32.2++

 

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

101.INS

 

XBRL Instance Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document.

 

 

 

 

 

 

 

 

 

+

Identifies a management contract or compensatory plan or arrangement.

 

++

Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities   Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

 

 

55